Amedeo Smart

Free Medical Literature Service


 

Amedeo

COVID-19

  Free Subscription

Articles published in
Lancet
    August 2022
  1. BALLERING AV, van Zon SKR, Olde Hartman TC, Rosmalen JGM, et al
    Persistence of somatic symptoms after COVID-19 in the Netherlands: an observational cohort study.
    Lancet. 2022;400:452-461.
    >> Share

  2. SORENSEN RJD
    COVID-19 and microbiome diversity in sub-Saharan Africa - Author's reply.
    Lancet. 2022;400:429-430.
    >> Share

  3. VAN DAMME W, Wamai R, Assefa Y, Liesenborghs L, et al
    COVID-19 and microbiome diversity in sub-Saharan Africa.
    Lancet. 2022;400:429.
    >> Share

  4. BRIGHTLING CE, Evans RA
    Long COVID: which symptoms can be attributed to SARS-CoV-2 infection?
    Lancet. 2022;400:411-413.
    >> Share

    July 2022

  5. Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.
    Lancet. 2022;400:359-368.
    >> Share

  6. THORNTON J
    Violence against health workers rises during COVID-19.
    Lancet. 2022;400:348.
    >> Share

  7. MEHTA P, Titanji BK
    Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality.
    Lancet. 2022;400:338-339.
    >> Share

  8. LAWTON T, Alwan NA
    The UK COVID-19 Inquiry must examine the foundations of pandemic decision making.
    Lancet. 2022 Jul 18. pii: S0140-6736(22)01332.
    >> Share


  9. Population-level risks of alcohol consumption by amount, geography, age, sex, and year: a systematic analysis for the Global Burden of Disease Study 2020.
    Lancet. 2022;400:185-235.
    >> Share

  10. MESSACAR K, Baker RE, Park SW, Nguyen-Tran H, et al
    Preparing for uncertainty: endemic paediatric viral illnesses after COVID-19 pandemic disruption.
    Lancet. 2022 Jul 14. pii: S0140-6736(22)01277.
    >> Share

  11. DURRHEIM DN
    Perilous two-tier COVID-19 global vaccine roll-out.
    Lancet. 2022 Jul 11. pii: S0140-6736(22)01284.
    >> Share

  12. WOLTER N, Jassat W, von Gottberg A, Cohen C, et al
    Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa.
    Lancet. 2022;400:93-96.
    >> Share

  13. MELLO MM, Opel DJ, Benjamin RM, Callaghan T, et al
    Effectiveness of vaccination mandates in improving uptake of COVID-19 vaccines in the USA.
    Lancet. 2022 Jul 8. pii: S0140-6736(22)00875.
    >> Share

  14. GOGA A, Bekker LG, Garrett N, Reddy T, et al
    Breakthrough SARS-CoV-2 infections during periods of delta and omicron predominance, South Africa.
    Lancet. 2022 Jul 6. pii: S0140-6736(22)01190.
    >> Share

  15. NASSIRI-ANSARI T, Atuhebwe P, Ayisi AS, Goulding S, et al
    Shifting gender barriers in immunisation in the COVID-19 pandemic response and beyond.
    Lancet. 2022;400:24.
    >> Share

  16. PFAFF F, Hoffmann D, Beer M
    Monkeypox genomic surveillance will challenge lessons learned from SARS-CoV-2.
    Lancet. 2022;400:22-23.
    >> Share

    June 2022
  17. SACCO C, Del Manso M, Mateo-Urdiales A, Rota MC, et al
    Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01185.
    >> Share

  18. LADHANI SN
    COVID-19 vaccination for children aged 5-11 years.
    Lancet. 2022 Jun 30. pii: S0140-6736(22)01245.
    >> Share

  19. BURKI T
    COVID-19 in North Korea.
    Lancet. 2022;399:2339.
    >> Share

  20. ANTONELLI M, Pujol JC, Spector TD, Ourselin S, et al
    Risk of long COVID associated with delta versus omicron variants of SARS-CoV-2.
    Lancet. 2022;399:2263-2264.
    >> Share

  21. OFRI D
    Memorialising COVID-19.
    Lancet. 2022;399:2260-2261.
    >> Share

  22. LI G, Cappuccini F, Marchevsky NG, Aley PK, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 (AZD1222) vaccine in children aged 6-17 years: a preliminary report of COV006, a phase 2 single-blind, randomised, controlled trial.
    Lancet. 2022;399:2212-2225.
    >> Share

  23. WONG HL, Hu M, Zhou CK, Lloyd PC, et al
    Risk of myocarditis and pericarditis after the COVID-19 mRNA vaccination in the USA: a cohort study in claims databases.
    Lancet. 2022;399:2191-2199.
    >> Share

  24. PATEL M, Patel M
    Increasing children's global access to COVID-19 vaccines.
    Lancet. 2022;399:2171-2173.
    >> Share

  25. HUSBY A, Kober L
    COVID-19 mRNA vaccination and myocarditis or pericarditis.
    Lancet. 2022;399:2168-2169.
    >> Share

    May 2022
  26. CLARK H, Cardenas M, Dybul M, Kazatchkine M, et al
    Transforming or tinkering: the world remains unprepared for the next pandemic threat.
    Lancet. 2022;399:1995-1999.
    >> Share

  27. NELLUMS LB, Latif A, Nkhoma K, Timmons S, et al
    COVID-19 boosters and building trust among UK minority ethnic communities.
    Lancet. 2022 May 25. pii: S0140-6736(22)00945.
    >> Share

  28. DENNEHY JJ, Gupta RK, Hanage WP, Johnson MC, et al
    Where is the next SARS-CoV-2 variant of concern?
    Lancet. 2022;399:1938-1939.
    >> Share

  29. KICKBUSCH I, Liu A
    Global health diplomacy-reconstructing power and governance.
    Lancet. 2022 May 17. pii: S0140-6736(22)00583.
    >> Share

  30. YUAN S
    Zero COVID in China: what next?
    Lancet. 2022;399:1856-1857.
    >> Share

  31. SHERLOCK PL
    COVID-19 and inter-generational solidarity.
    Lancet. 2022;399:1775.
    >> Share

  32. THE LANCET
    COVID-19: the next phase and beyond.
    Lancet. 2022;399:1753.
    >> Share

  33. BHUTTA ZA, Boerma T, Black MM, Victora CG, et al
    Optimising child and adolescent health and development in the post-pandemic world.
    Lancet. 2022;399:1759-1761.
    >> Share

  34. JHA P, Brown PE, Ansumana R
    Counting the global COVID-19 dead.
    Lancet. 2022 May 6. pii: S0140-6736(22)00845.
    >> Share

  35. ZHANG X, Zhang W, Chen S
    Shanghai's life-saving efforts against the current omicron wave of the COVID-19 pandemic.
    Lancet. 2022 May 6. pii: S0140-6736(22)00838.
    >> Share

  36. CHRISTENSON SA, Smith BM, Bafadhel M, Putcha N, et al
    Chronic obstructive pulmonary disease.
    Lancet. 2022 May 6. pii: S0140-6736(22)00470.
    >> Share

  37. DZAU VJ, Balatbat CA, Offodile AC 2nd
    Closing the global vaccine equity gap: equitably distributed manufacturing.
    Lancet. 2022 May 6. pii: S0140-6736(22)00793.
    >> Share


  38. Remdesivir and three other drugs for hospitalised patients with COVID-19: final results of the WHO Solidarity randomised trial and updated meta-analyses.
    Lancet. 2022 May 2. pii: S0140-6736(22)00519.
    >> Share

    April 2022
  39. ADEPOJU P
    Africa CDC warns COVID-19 vaccine production could cease.
    Lancet. 2022;399:1683.
    >> Share

  40. VICTORA CG, Hartwig FP, Vidaletti LP, Martorell R, et al
    Effects of early-life poverty on health and human capital in children and adolescents: analyses of national surveys and birth cohort studies in LMICs.
    Lancet. 2022;399:1741-1752.
    >> Share

  41. ARCHARD D, Buyx A, Delfraissy JF
    Responding to the humanitarian crisis of the war in Ukraine with lessons from COVID-19.
    Lancet. 2022 Apr 25. pii: S0140-6736(22)00731.
    >> Share

  42. GRAMMATOPOULOS DK, Young L, Anderson NR
    Transforming the UK's diagnostics agenda after COVID-19.
    Lancet. 2022;399:1606.
    >> Share

  43. JEFFORD M, Howell D, Li Q, Lisy K, et al
    Improved models of care for cancer survivors.
    Lancet. 2022;399:1551-1560.
    >> Share

  44. FISHER D, Suri S, Carson G
    What comes next in the COVID-19 pandemic?
    Lancet. 2022 Apr 11. pii: S0140-6736(22)00580.
    >> Share

  45. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    COVID-19 vaccination and HIV-1 acquisition - Authors' reply.
    Lancet. 2022;399:e36.
    >> Share

  46. LOGUNOV DY, Livermore DM, Ornelles DA, Bayer W, et al
    COVID-19 vaccination and HIV-1 acquisition.
    Lancet. 2022;399:e34-e35.
    >> Share

  47. DWEK RA, Bell JI, Feldmann M, Zitzmann N, et al
    Host-targeting oral antiviral drugs to prevent pandemics.
    Lancet. 2022;399:1381-1382.
    >> Share


  48. Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00484.
    >> Share

  49. SHIODA K, Lopman B
    How to interpret the total number of SARS-CoV-2 infections.
    Lancet. 2022 Apr 8. pii: S0140-6736(22)00629.
    >> Share

  50. MENNI C, Valdes AM, Polidori L, Antonelli M, et al
    Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00327.
    >> Share

  51. HAN X, Li J, Chen Y, Li Y, et al
    SARS-CoV-2 nucleic acid testing is China's key pillar of COVID-19 containment.
    Lancet. 2022 Apr 7. pii: S0140-6736(22)00577.
    >> Share

  52. BERGMARK BA, Mathenge N, Merlini PA, Lawrence-Wright MB, et al
    Acute coronary syndromes.
    Lancet. 2022;399:1347-1358.
    >> Share

  53. KHOBRAGADE A, Bhate S, Ramaiah V, Deshpande S, et al
    Efficacy, safety, and immunogenicity of the DNA SARS-CoV-2 vaccine (ZyCoV-D): the interim efficacy results of a phase 3, randomised, double-blind, placebo-controlled study in India.
    Lancet. 2022;399:1313-1321.
    >> Share

  54. ZAROCOSTAS J
    Mixed response to COVID-19 intellectual property waiver.
    Lancet. 2022;399:1292-1293.
    >> Share

  55. BLAKNEY AK, Bekker LG
    DNA vaccines join the fight against COVID-19.
    Lancet. 2022;399:1281-1282.
    >> Share

  56. POST LA, Lorenzo-Redondo R
    Omicron: fewer adverse outcomes come with new dangers.
    Lancet. 2022;399:1280-1281.
    >> Share

    March 2022
  57. LUKE JJ, Rutkowski P, Queirolo P, Del Vecchio M, et al
    Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
    Lancet. 2022 Mar 31. pii: S0140-6736(22)00562.
    >> Share


  58. NCD Countdown 2030: efficient pathways and strategic investments to accelerate progress towards the Sustainable Development Goal target 3.4 in low-income and middle-income countries.
    Lancet. 2022;399:1266-1278.
    >> Share

  59. KRAUSE PR, Rees H, Figueroa JP, Swaminathan S, et al
    Booster vaccines for COVID-19 vaccine breakthrough cases? - Authors' reply.
    Lancet. 2022;399:1225.
    >> Share

  60. NIXON DF, Schwartz RE, Ndhlovu LC
    Booster vaccines for COVID-19 vaccine breakthrough cases?
    Lancet. 2022;399:1224.
    >> Share

  61. SWETS MC, Russell CD, Harrison EM, Docherty AB, et al
    SARS-CoV-2 co-infection with influenza viruses, respiratory syncytial virus, or adenoviruses.
    Lancet. 2022 Mar 25. pii: S0140-6736(22)00383.
    >> Share

  62. KOLA L, Kumar M, Kohrt BA, Fatodun T, et al
    Strengthening public mental health during and after the acute phase of the COVID-19 pandemic.
    Lancet. 2022 Mar 24. pii: S0140-6736(22)00523.
    >> Share

  63. WATERS L, Marra F, Pozniak A, Cockburn J, et al
    Ritonavir and COVID-19: pragmatic guidance is important.
    Lancet. 2022 Mar 22. pii: S0140-6736(22)00280.
    >> Share

  64. BEKKER LG, Garrett N, Goga A, Fairall L, et al
    Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
    Lancet. 2022;399:1141-1153.
    >> Share

  65. PREISER W, Fish T
    Sisonke: reaching several goals together.
    Lancet. 2022;399:1095-1097.
    >> Share

  66. NYBERG T, Ferguson NM, Nash SG, Webster HH, et al
    Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study.
    Lancet. 2022 Mar 16. pii: S0140-6736(22)00462.
    >> Share

  67. REARTE A, Castelli JM, Rearte R, Fuentes N, et al
    Effectiveness of rAd26-rAd5, ChAdOx1 nCoV-19, and BBIBP-CorV vaccines for risk of infection with SARS-CoV-2 and death due to COVID-19 in people older than 60 years in Argentina: a test-negative, case-control, and retrospective longitudinal study.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00011.
    >> Share

  68. MILLS EJ, Reis G
    Evaluating COVID-19 vaccines in the real world.
    Lancet. 2022 Mar 15. pii: S0140-6736(22)00194.
    >> Share

  69. YEN HL, Sit THC, Brackman CJ, Chuk SSY, et al
    Transmission of SARS-CoV-2 delta variant (AY.127) from pet hamsters to humans, leading to onward human-to-human transmission: a case study.
    Lancet. 2022;399:1070-1078.
    >> Share

  70. HAAGMANS BL, Koopmans MPG
    Spreading of SARS-CoV-2 from hamsters to humans.
    Lancet. 2022;399:1027-1028.
    >> Share

  71. KHAN W, Abubakar A, Brennan RJ, Al Hosani F, et al
    Preparing for future pandemics in the Eastern Mediterranean region.
    Lancet. 2022;399:1032-1033.
    >> Share

  72. ABUBAKAR I, Dalglish SL, Angell B, Sanuade O, et al
    The Lancet Nigeria Commission: investing in health and the future of the nation.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02488.
    >> Share

  73. ANGELL B, Sanuade O, Adetifa IMO, Okeke IN, et al
    Population health outcomes in Nigeria compared with other west African countries, 1998-2019: a systematic analysis for the Global Burden of Disease Study.
    Lancet. 2022 Mar 11. pii: S0140-6736(21)02722.
    >> Share


  74. Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
    Lancet. 2022 Mar 10. pii: S0140-6736(21)02796.
    >> Share

  75. MANCA T, Baylis F, Munoz FM, Top KA, et al
    Prioritise research on vaccines for pregnant and breastfeeding women.
    Lancet. 2022;399:890-893.
    >> Share

  76. FALLAH MP, Reinhart E
    Apartheid logic in global health.
    Lancet. 2022;399:902-903.
    >> Share

  77. CORREIA LCL, Sette C, Santos M, Magliano CAS, et al
    Brazil's COVID-19 guidelines: political hijack of public health.
    Lancet. 2022 Mar 3. pii: S0140-6736(22)00338.
    >> Share

  78. KUCHARSKI AJ, Jit M, Logan JG, Cotten M, et al
    Travel measures in the SARS-CoV-2 variant era need clear objectives.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00366.
    >> Share

  79. FLOR LS, Friedman J, Spencer CN, Cagney J, et al
    Quantifying the effects of the COVID-19 pandemic on gender equality on health, social, and economic indicators: a comprehensive review of data from March, 2020, to September, 2021.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00008.
    >> Share

  80. MORGAN R, Pimenta DN, Rashid S
    Gender equality and COVID-19: act now before it is too late.
    Lancet. 2022 Mar 2. pii: S0140-6736(22)00278.
    >> Share

    February 2022
  81. USHER AD
    The global COVID-19 treatment divide.
    Lancet. 2022;399:779-782.
    >> Share

  82. CHEMAITELLY H, Abu-Raddad LJ
    Waning effectiveness of COVID-19 vaccines.
    Lancet. 2022;399:771-773.
    >> Share

  83. THE LANCET
    Our commitment to help accelerate progress against cancer.
    Lancet. 2022;399:769.
    >> Share


  84. Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.
    Lancet. 2022 Feb 24. pii: S0140-6736(21)02867.
    >> Share

  85. GU X, Cao B
    Understanding of COVID-19 from infection-fatality ratio.
    Lancet. 2022 Feb 24. pii: S0140-6736(22)00281.
    >> Share

  86. BAJAJ SS, Maki L, Stanford FC
    Vaccine apartheid: global cooperation and equity.
    Lancet. 2022 Feb 23. pii: S0140-6736(22)00328.
    >> Share

  87. PIECHOTTA V, Harder T
    Waning of COVID-19 vaccine effectiveness: individual and public health risk.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00282.
    >> Share

  88. FEIKIN DR, Higdon MM, Abu-Raddad LJ, Andrews N, et al
    Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression.
    Lancet. 2022 Feb 21. pii: S0140-6736(22)00152.
    >> Share

  89. MADHI SA, Ihekweazu C, Rees H, Pollard AJ, et al
    Decoupling of omicron variant infections and severe COVID-19.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00109.
    >> Share

  90. KALAFAT E, Magee LA, von Dadelszen P, Heath P, et al
    COVID-19 booster doses in pregnancy and global vaccine equity.
    Lancet. 2022 Feb 18. pii: S0140-6736(22)00166.
    >> Share

  91. SARDINHA L, Maheu-Giroux M, Stockl H, Meyer SR, et al
    Global, regional, and national prevalence estimates of physical or sexual, or both, intimate partner violence against women in 2018.
    Lancet. 2022 Feb 16. pii: S0140-6736(21)02664.
    >> Share

  92. DINEEN K, Autzen B, Alwan NA
    Children, intersectionality, and COVID-19.
    Lancet. 2022 Feb 16. pii: S0140-6736(22)00174.
    >> Share


  93. Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2022;399:665-676.
    >> Share

  94. EGGER S, Egger G
    The vaccinated propor-tion of people with COVID-19 needs context.
    Lancet. 2022;399:627.
    >> Share

  95. HORTON R
    Offline: Complacency threatens progress against COVID-19.
    Lancet. 2022;399:615.
    >> Share

  96. MUSSINI C, Cozzi-Lepri A
    Another piece in the COVID-19 treatment puzzle.
    Lancet. 2022;399:609-610.
    >> Share

  97. ADAMS LV, Dorough DS
    Accelerating Indigenous health and wellbeing: the Lancet Commission on Arctic and Northern Health.
    Lancet. 2022;399:613-614.
    >> Share

  98. LOPEZ A, Srigley J
    Transmission of SARS-CoV-2: still up in the air.
    Lancet. 2022;399:519.
    >> Share

  99. GREENHALGH T, Jimenez JL, Prather KA, Tufeki Z, et al
    Transmission of SARS-CoV-2: still up in the air - Authors' reply.
    Lancet. 2022;399:519-520.
    >> Share

  100. DALY M, Robinson E
    Depression and anxiety during COVID-19.
    Lancet. 2022;399:518.
    >> Share

  101. SANTOMAURO DF, Whiteford HA, Ferrari AJ
    Depression and anxiety during COVID-19 - Authors' reply.
    Lancet. 2022;399:518-519.
    >> Share

  102. SAMARASEKERA U
    Ayoade Alakija: advancing equity in the COVID-19 response.
    Lancet. 2022;399:511.
    >> Share

  103. ZAROCOSTAS J
    WHO concerned over COVID-19 health-care waste.
    Lancet. 2022;399:507.
    >> Share

  104. BURKI T
    Fresh questions over Gates Foundation governance.
    Lancet. 2022;399:508.
    >> Share

  105. HUMPHREYS K, Shover CL, Andrews CM, Bohnert ASB, et al
    Responding to the opioid crisis in North America and beyond: recommendations of the Stanford-Lancet Commission.
    Lancet. 2022;399:555-604.
    >> Share

  106. THE LANCET
    Managing the opioid crisis in North America and beyond.
    Lancet. 2022;399:495.
    >> Share

  107. BEYRER C
    Archbishop Desmond Tutu and the universality of health and human rights.
    Lancet. 2022;399:503-504.
    >> Share

  108. NORDSTROM P, Ballin M, Nordstrom A
    Risk of infection, hospitalisation, and death up to 9 months after a second dose of COVID-19 vaccine: a retrospective, total population cohort study in Sweden.
    Lancet. 2022 Feb 4. pii: S0140-6736(22)00089.
    >> Share

  109. KARAFILLAKIS E, Van Damme P, Hendrickx G, Larson HJ, et al
    COVID-19 in Europe: new challenges for addressing vaccine hesitancy.
    Lancet. 2022 Feb 3. pii: S0140-6736(22)00150.
    >> Share


  110. Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.
    Lancet. 2022 Feb 1. pii: S0140-6736(22)00172.
    >> Share

    January 2022
  111. HOLT E
    Polish Government COVID-19 advisors resign.
    Lancet. 2022;399:424.
    >> Share

  112. NEALON J, Cowling BJ
    Omicron severity: milder but not mild.
    Lancet. 2022;399:412-413.
    >> Share

  113. ADAMS R
    Urgent care: disability, pandemic, and the value of a life.
    Lancet. 2022;399:430-431.
    >> Share

  114. JAFFE S
    The next steps for US vaccine mandates.
    Lancet. 2022;399:425-426.
    >> Share

  115. SO-OSMAN C, Valk SJ
    High-dose immunoglobulins from convalescent donors for patients hospitalised with COVID-19.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00112.
    >> Share

  116. HUBSCHEN JM, Gouandjika-Vasilache I, Dina J
    Measles.
    Lancet. 2022 Jan 27. pii: S0140-6736(21)02004.
    >> Share


  117. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial.
    Lancet. 2022 Jan 27. pii: S0140-6736(22)00101.
    >> Share

  118. FENDLER A, Shepherd STC, Au L, Wu M, et al
    Omicron neutralising antibodies after third COVID-19 vaccine dose in patients with cancer.
    Lancet. 2022 Jan 25. pii: S0140-6736(22)00147.
    >> Share

  119. TANG TB
    The COVID-19 response in Hong Kong.
    Lancet. 2022;399:357.
    >> Share

  120. ALFIERI C, Egrot M, Desclaux A, Sams K, et al
    Recognising Italy's mistakes in the public health response to COVID-19.
    Lancet. 2022;399:357-358.
    >> Share

  121. BROWN K, Yahyouche A, Haroon S, Camaradou J, et al
    Long COVID and self-management.
    Lancet. 2022;399:355.
    >> Share

  122. HORTON R
    Offline: COVID-19 as culture war.
    Lancet. 2022;399:346.
    >> Share

  123. QURESHI I, Gogoi M, Al-Oraibi A, Wobi F, et al
    Intersectionality and developing evidence-based policy.
    Lancet. 2022;399:355-356.
    >> Share

  124. LANE R
    Jamal Rifi: family doctor building bridges in the community.
    Lancet. 2022;399:353.
    >> Share

  125. COSTA CLEMENS SA, Weckx L, Clemens R, Almeida Mendes AV, et al
    Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study.
    Lancet. 2022 Jan 21. pii: S0140-6736(22)00094.
    >> Share

  126. BRAVO L, Smolenov I, Han HH, Li P, et al
    Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00055.
    >> Share

  127. VESIKARI T
    Trimeric S protein COVID-19 vaccine needs to find its place.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00096.
    >> Share

  128. CARR EJ, Wu M, Harvey R, Billany RE, et al
    Omicron neutralising antibodies after COVID-19 vaccination in haemodialysis patients.
    Lancet. 2022 Jan 20. pii: S0140-6736(22)00104.
    >> Share

  129. WOLTER N, Jassat W, Walaza S, Welch R, et al
    Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00017.
    >> Share

  130. MURRAY CJL
    COVID-19 will continue but the end of the pandemic is near.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00100.
    >> Share

  131. WU M, Wall EC, Carr EJ, Harvey R, et al
    Three-dose vaccination elicits neutralising antibodies against omicron.
    Lancet. 2022 Jan 19. pii: S0140-6736(22)00092.
    >> Share


  132. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
    Lancet. 2022 Jan 18. pii: S0140-6736(21)02724.
    >> Share

  133. KUHLMANN C, Mayer CK, Claassen M, Maponga T, et al
    Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00090.
    >> Share

  134. LAXMINARAYAN R
    The overlooked pandemic of antimicrobial resistance.
    Lancet. 2022 Jan 18. pii: S0140-6736(22)00087.
    >> Share

  135. VALAIYAPATHI R, Wu MS, McGregor A
    Ground glass opacities are not always COVID-19: a case of acute eosinophilic pneumonitis caused by daptomycin.
    Lancet. 2022;399:270.
    >> Share

  136. MCCALL C
    Disrupted care in Papua New Guinea: the harms of COVID-19.
    Lancet. 2022;399:226-227.
    >> Share

  137. PUNTIS JWL
    The UK People's Covid Inquiry.
    Lancet. 2022;399:236.
    >> Share

  138. HARMAN S
    The wall.
    Lancet. 2022;399:136-137.
    >> Share

  139. BARBARO RP, MacLaren G, Swol J, Slutsky AS, et al
    COVID-19 ARDS: getting ventilation right - Authors' reply.
    Lancet. 2022;399:22-23.
    >> Share

  140. PEREZ-FERNANDEZ XL, Sabater-Riera J, Fuset-Cabanes M
    COVID-19 ARDS: getting ventilation right.
    Lancet. 2022;399:22.
    >> Share

  141. HESKIN J, Pallett SJC, Mughal N, Davies GW, et al
    Caution required with use of ritonavir-boosted PF-07321332 in COVID-19 management.
    Lancet. 2022;399:21-22.
    >> Share

  142. THE LANCET
    The state of science and society in 2022.
    Lancet. 2022;399:1.
    >> Share

    December 2021
  143. KING J, Ferraz OLM, Jones A
    Mandatory COVID-19 vaccination and human rights.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02873.
    >> Share

  144. HALPERIN SA, Ye L, MacKinnon-Cameron D, Smith B, et al
    Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02753.
    >> Share

  145. KENNEDY RB
    Efficacy of an adenovirus type 5 vectored SARS-CoV-2 vaccine.
    Lancet. 2021 Dec 23. pii: S0140-6736(21)02834.
    >> Share

  146. ORMISTON CK, Williams F
    LGBTQ youth mental health during COVID-19: unmet needs in public health and policy.
    Lancet. 2021 Dec 22. pii: S0140-6736(21)02872.
    >> Share

  147. LEUNG K, Wu JT
    Managing waning vaccine protection against SARS-CoV-2 variants.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02841.
    >> Share

  148. KATIKIREDDI SV, Cerqueira-Silva T, Vasileiou E, Robertson C, et al
    Two-dose ChAdOx1 nCoV-19 vaccine protection against COVID-19 hospital admissions and deaths over time: a retrospective, population-based cohort study in Scotland and Brazil.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02754.
    >> Share

  149. PEELING RW, Heymann DL, Teo YY, Garcia PJ, et al
    Diagnostics for COVID-19: moving from pandemic response to control.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02346.
    >> Share

  150. DEJNIRATTISAI W, Shaw RH, Supasa P, Liu C, et al
    Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum.
    Lancet. 2021 Dec 20. pii: S0140-6736(21)02844.
    >> Share

  151. HORTON R
    Offline: The lessons of smallpox eradication for COVID-19.
    Lancet. 2021;396:1951.
    >> Share

  152. THE LANCET
    Science during COVID-19: where do we go from here?
    Lancet. 2021;396:1941.
    >> Share

  153. FLEISHMAN R
    Dreams deferred.
    Lancet. 2021;396:2083-2084.
    >> Share

  154. DANIELS JP
    Caribbean rainy season batters health care.
    Lancet. 2021;396:1955.
    >> Share

  155. HALL V, Hopkins S
    COV-BOOST: evidence to support rapid booster deployment.
    Lancet. 2021;398:2209-2211.
    >> Share

  156. THE LANCET
    COVID-19: where do we go from here?
    Lancet. 2021;398:2207.
    >> Share

  157. MOLLICA RF, Fricchione GL
    Mental and physical exhaustion of health-care practitioners.
    Lancet. 2021;398:2243-2244.
    >> Share

  158. ZAROCOSTAS J
    WHO and World Bank urge spending for UHC.
    Lancet. 2021;398:2223.
    >> Share

  159. DEVI S
    Russia-Ukraine tensions hampering health-care access.
    Lancet. 2021;398:2222.
    >> Share

  160. COVIDSURG COLLABORATIVE
    Projecting COVID-19 disruption to elective surgery.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02836.
    >> Share

  161. MCINTYRE PB, Aggarwal R, Jani I, Jawad J, et al
    COVID-19 vaccine strategies must focus on severe disease and global equity.
    Lancet. 2021 Dec 16. pii: S0140-6736(21)02835.
    >> Share

  162. BRADBURY CA, McQuilten Z
    Anticoagulation in COVID-19.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02503.
    >> Share

  163. RAMACCIOTTI E, Barile Agati L, Calderaro D, Aguiar VCR, et al
    Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Dec 15. pii: S0140-6736(21)02392.
    >> Share

  164. LIPWORTH B, Chan R, Misirovs R
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2147.
    >> Share

  165. HOBBS FDR, Yu LM, Saville BR, Bafadhel M, et al
    High-dose budesonide for early COVID-19 - Authors' reply.
    Lancet. 2021;398:2147-2148.
    >> Share

  166. BEREZOWSKI I, Patel J, Shaw M, Pourmand A, et al
    High-dose budesonide for early COVID-19.
    Lancet. 2021;398:2146-2147.
    >> Share

  167. SASO A, Skirrow H, Kampmann B
    Prioritising immunisation across the life course.
    Lancet. 2021;398:2145.
    >> Share

  168. THE LANCET
    Preventing violence against women: beyond 16 days.
    Lancet. 2021;398:2125.
    >> Share

  169. MOON S, Armstrong J, Hutler B, Upshur R, et al
    Governing the Access to COVID-19 Tools Accelerator: towards greater participation, transparency, and accountability.
    Lancet. 2021 Dec 10. pii: S0140-6736(21)02344.
    >> Share

  170. STUART ASV, Shaw RH, Liu X, Greenland M, et al
    Immunogenicity, safety, and reactogenicity of heterologous COVID-19 primary vaccination incorporating mRNA, viral-vector, and protein-adjuvant vaccines in the UK (Com-COV2): a single-blind, randomised, phase 2, non-inferiority trial.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02718.
    >> Share

  171. RICHARDSON CD
    Mixing mRNA, adenoviral, and spike-adjuvant vaccines for protection against COVID-19.
    Lancet. 2021 Dec 6. pii: S0140-6736(21)02757.
    >> Share

  172. EMANUEL EJ, Fabre C, Herzog L, Norheim OF, et al
    Obligations in a global health emergency - Authors' reply.
    Lancet. 2021;398:2072.
    >> Share

  173. DEVI S
    Health warnings over UNRWA funding shortfall.
    Lancet. 2021;398:2063.
    >> Share

  174. ZAROCOSTAS J
    Hope for nutrition summit as global hunger spikes.
    Lancet. 2021;398:2061-2062.
    >> Share

  175. WARD H, Flower B, Garcia PJ, Ong SWX, et al
    Global surveillance, research, and collaboration needed to improve understanding and management of long COVID.
    Lancet. 2021;398:2057-2059.
    >> Share

  176. KARIM SSA, Karim QA
    Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02758.
    >> Share

  177. MENDELSON M, Venter F, Moshabela M, Gray G, et al
    The political theatre of the UK's travel ban on South Africa.
    Lancet. 2021 Dec 3. pii: S0140-6736(21)02752.
    >> Share

  178. MUNRO APS, Janani L, Cornelius V, Aley PK, et al
    Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
    Lancet. 2021 Dec 2. pii: S0140-6736(21)02717.
    >> Share

    November 2021
  179. SIMBAYI LC, Moyo S, van Heerden A, Zuma K, et al
    Global HIV efforts need to focus on key populations in LMICs.
    Lancet. 2021 Nov 29. pii: S0140-6736(21)02692.
    >> Share

  180. CALDEIRA D, Pinto FJ
    COVID-19 and myocardial infarction.
    Lancet. 2021;398:1963-1964.
    >> Share

  181. BOUM Y
    Beyond COVID-19: scaling up and sustaining mobile health in Africa.
    Lancet. 2021;398:1962-1963.
    >> Share

  182. JOLLY J
    A reproductive justice response to HIV/AIDS and COVID-19.
    Lancet. 2021;398:1958-1959.
    >> Share

  183. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    COVID-19 and myocardial infarction - Authors' reply.
    Lancet. 2021;398:1964.
    >> Share

  184. SAWADOGO NH, Sanou H, Greene JA, Duclos V, et al
    Beyond COVID-19: scaling up and sustaining mobile health in Africa - Authors' reply.
    Lancet. 2021;398:1963.
    >> Share

  185. SMITH K, Brooks W, Challiner J, Povey E, et al
    Quality assurance of remote clinical assessments in the NHS.
    Lancet. 2021;398:1962.
    >> Share

  186. LANE R
    Pascale Ondoa: strengthening laboratory medicine in Africa.
    Lancet. 2021;398:1955.
    >> Share

  187. FLEMING KA, Horton S, Wilson ML, Atun R, et al
    The Lancet Commission on diagnostics: transforming access to diagnostics.
    Lancet. 2021;398:1997-2050.
    >> Share

  188. YANG C, Zhao H, Tebbutt SJ
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1872.
    >> Share

  189. HUANG L, Gu X, Cao B
    Long-term effects on survivors with COVID-19 - Authors' reply.
    Lancet. 2021;398:1872-1873.
    >> Share

  190. KAMPF G
    COVID-19: stigmatising the unvaccinated is not justified.
    Lancet. 2021;398:1871.
    >> Share

  191. ZHAO YJ, Bai W, Su Z, Ng CH, et al
    Long-term effects on survivors with COVID-19.
    Lancet. 2021;398:1871-1872.
    >> Share

  192. JAFFE S
    Legal challenges threaten Biden's COVID-19 vaccine rule.
    Lancet. 2021;398:1863-1864.
    >> Share

  193. KNEEBONE R, Houstoun W, Houghton N
    Medicine, magic, and online performance.
    Lancet. 2021;398:1868-1869.
    >> Share

  194. BURKI T
    mRNA discoveries earn the 2021 Prince Mahidol Award.
    Lancet. 2021;398:1865.
    >> Share


  195. Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01825.
    >> Share

  196. SPYROPOULOS AC, Bonaca MP
    Studying the coagulopathy of COVID-19.
    Lancet. 2021 Nov 17. pii: S0140-6736(21)01906.
    >> Share

  197. OMER SB, Benjamin RM, Brewer NT, Buttenheim AM, et al
    Promoting COVID-19 vaccine acceptance: recommendations from the Lancet Commission on Vaccine Refusal, Acceptance, and Demand in the USA.
    Lancet. 2021 Nov 15. pii: S0140-6736(21)02507.
    >> Share

  198. BHUTTA ZA, Salam RA, Gomber A, Lewis-Watts L, et al
    A century past the discovery of insulin: global progress and challenges for type 1 diabetes among children and adolescents in low-income and middle-income countries.
    Lancet. 2021;398:1837-1850.
    >> Share

  199. PAVORD S, Scully M, Lester W, Makris M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine?
    Lancet. 2021;398:1801.
    >> Share

  200. BHUYAN P, Medin J, da Silva HG, Yadavalli M, et al
    Just how common is TTS after a second dose of the ChAdOx1 nCov-19 vaccine? - Authors' reply.
    Lancet. 2021;398:1801-1802.
    >> Share

  201. LAZARUS R, Baos S, Cappel-Porter H, Carson-Stevens A, et al
    Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02329.
    >> Share

  202. ELLA R, Reddy S, Blackwelder W, Potdar V, et al
    Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02000.
    >> Share

  203. LI JX, Zhu FC
    Inactivated SARS-CoV-2 vaccine (BBV152)-induced protection against symptomatic COVID-19.
    Lancet. 2021 Nov 11. pii: S0140-6736(21)02014.
    >> Share

  204. SINGH S, McNab C, Olson RM, Bristol N, et al
    How an outbreak became a pandemic: a chronological analysis of crucial junctures and international obligations in the early months of the COVID-19 pandemic.
    Lancet. 2021 Nov 8. pii: S0140-6736(21)01897.
    >> Share

  205. ALVES L
    Health experts welcome Brazil COVID-19 inquiry findings.
    Lancet. 2021;398:1674-1675.
    >> Share

  206. KICKBUSCH I, Piselli D, Agrawal A, Balicer R, et al
    The Lancet and Financial Times Commission on governing health futures 2030: growing up in a digital world.
    Lancet. 2021;398:1727-1776.
    >> Share

  207. MCMULLEN AM
    The choice to love.
    Lancet. 2021;398:1680-1681.
    >> Share

  208. USHER AD
    New budget and strategy for ACT-A.
    Lancet. 2021;398:1677.
    >> Share

  209. ZAROCOSTAS J
    WHO's Tedros set to be re-elected unopposed.
    Lancet. 2021;398:1676.
    >> Share

  210. THE LANCET
    Can digital technologies improve health?
    Lancet. 2021;398:1663.
    >> Share

  211. ORTIZ JR, Neuzil KM
    The value of vaccine programme impact monitoring during the COVID-19 pandemic.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02322.
    >> Share

  212. MCNAMARA LA, Wiegand RE, Burke RM, Sharma AJ, et al
    Estimating the early impact of the US COVID-19 vaccination programme on COVID-19 cases, emergency department visits, hospital admissions, and deaths among adults aged 65 years and older: an ecological analysis of national surveillance data.
    Lancet. 2021 Nov 3. pii: S0140-6736(21)02226.
    >> Share

    October 2021

  213. Global, regional, and national mortality among young people aged 10-24 years, 1950-2019: a systematic analysis for the Global Burden of Disease Study 2019.
    Lancet. 2021;398:1593-1618.
    >> Share

  214. GOLD C
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation.
    Lancet. 2021;398:1566.
    >> Share

  215. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    Unclear conclusions on SARS-CoV-2 elimination versus mitigation - Authors' reply.
    Lancet. 2021;398:1566-1567.
    >> Share

  216. DANIELS JP
    Nicaraguan health-care workers under attack.
    Lancet. 2021;398:1555-1556.
    >> Share

  217. BAR-YAM Y, Gurdasani D, Baker MG, Scally G, et al
    The World Health Network: a global citizens' initiative.
    Lancet. 2021;398:1567-1568.
    >> Share

  218. HODGES S, Hornberger J, Kufakurinani U, Rudra S, et al
    When suspicion replaces evidence in public health.
    Lancet. 2021;398:1565-1566.
    >> Share

  219. BARDA N, Dagan N, Cohen C, Hernan MA, et al
    Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study.
    Lancet. 2021 Oct 29. pii: S0140-6736(21)02249.
    >> Share

  220. GRANGE Z, Buelo A, Sullivan C, Moore E, et al
    Characteristics and risk of COVID-19-related death in fully vaccinated people in Scotland.
    Lancet. 2021 Oct 28. pii: S0140-6736(21)02316.
    >> Share

  221. LEUNG GM
    Nowcasting towards sustainable SARS-CoV-2 endemicity.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02386.
    >> Share

  222. SONABEND R, Whittles LK, Imai N, Perez-Guzman PN, et al
    Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study.
    Lancet. 2021 Oct 27. pii: S0140-6736(21)02276.
    >> Share

  223. XUE W, White A
    COVID-19 and the rebiologisation of racial difference.
    Lancet. 2021;398:1479-1480.
    >> Share

  224. MAKONI M
    African Medicines Agency to be established.
    Lancet. 2021;398:1475.
    >> Share

  225. USHER AD
    Vaccine shortages prompt changes to COVAX strategy.
    Lancet. 2021;398:1474.
    >> Share


  226. The Lancet Commission on water, sanitation and hygiene, and health.
    Lancet. 2021;398:1469-1470.
    >> Share

  227. RICCIARDI W, Tarricone R
    The evolution of the Italian National Health Service.
    Lancet. 2021 Oct 22. pii: S0140-6736(21)01733.
    >> Share

  228. HILLSON K, Clemens SC, Madhi SA, Voysey M, et al
    Fertility rates and birth outcomes after ChAdOx1 nCoV-19 (AZD1222) vaccination.
    Lancet. 2021 Oct 21. pii: S0140-6736(21)02282.
    >> Share

  229. SAAG MS
    Developing COVID-19 vaccine policy in increments.
    Lancet. 2021;398:1382-1383.
    >> Share

  230. LOPES RD, de Barros E Silva PGM, Furtado RHM, Alexander JH, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19 - Authors' reply.
    Lancet. 2021;398:1304.
    >> Share

  231. ZUIN M, Rigatelli G, Zuliani G, Roncon L, et al
    Age-adjusted D-dimer cutoffs to guide anticoagulation in COVID-19.
    Lancet. 2021;398:1303-1304.
    >> Share

  232. MYERS SS, Pivor JI, Saraiva AM
    The Sao Paulo Declaration on Planetary Health.
    Lancet. 2021;398:1299.
    >> Share

  233. TAQUET M, Holmes EA, Harrison PJ
    Depression and anxiety disorders during the COVID-19 pandemic: knowns and unknowns.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02221.
    >> Share


  234. Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic.
    Lancet. 2021 Oct 8. pii: S0140-6736(21)02143.
    >> Share

  235. KOLA L, Kohrt BA, Acharya B, Mutamba BB, et al
    The path to global equity in mental health care in the context of COVID-19.
    Lancet. 2021 Oct 7. pii: S0140-6736(21)02233.
    >> Share

  236. KLEINERT S, Horton R
    Can COVID-19 help accelerate and transform the diagnostics agenda?
    Lancet. 2021 Oct 5. pii: S0140-6736(21)02093.
    >> Share

  237. PRENDECKI M, Thomson T, Clarke CL, Martin P, et al
    Immunological responses to SARS-CoV-2 vaccines in kidney transplant recipients.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02096.
    >> Share

  238. DE FOO C, Grepin KA, Cook AR, Hsu LY, et al
    Navigating from SARS-CoV-2 elimination to endemicity in Australia, Hong Kong, New Zealand, and Singapore.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02186.
    >> Share

  239. TARTOF SY, Slezak JM, Fischer H, Hong V, et al
    Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study.
    Lancet. 2021 Oct 4. pii: S0140-6736(21)02183.
    >> Share

  240. TORRES I, Profeta B, Machado CV, Artaza O, et al
    COVID-19 research in LMICs - Authors' reply.
    Lancet. 2021;398:1213.
    >> Share

  241. SISA I, Fornasini M, Teran E
    COVID-19 research in LMICs.
    Lancet. 2021;398:1212-1213.
    >> Share

  242. BARBARO RP, MacLaren G, Boonstra PS, Combes A, et al
    Extracorporeal membrane oxygenation for COVID-19: evolving outcomes from the international Extracorporeal Life Support Organization Registry.
    Lancet. 2021;398:1230-1238.
    >> Share

  243. VUYLSTEKE A
    ECMO in COVID-19: do not blame the tool.
    Lancet. 2021;398:1197-1199.
    >> Share

  244. VINER RM, Koirala A
    Daily antigen testing to reduce disruption when schools return.
    Lancet. 2021;398:1196-1197.
    >> Share

    September 2021
  245. PINTO FJ, Pineiro D, Banerjee A, Perel P, et al
    World Heart Day 2021: COVID-19, digital health, and tackling cardiovascular disease.
    Lancet. 2021 Sep 28. pii: S0140-6736(21)02144.
    >> Share

  246. THE LANCET
    COVID-19: learning as an interdependent world.
    Lancet. 2021;398:1105.
    >> Share

  247. AAVITSLAND P, Aguilera X, Al-Abri SS, Amani V, et al
    Functioning of the International Health Regulations during the COVID-19 pandemic.
    Lancet. 2021 Sep 24. pii: S0140-6736(21)01911.
    >> Share

  248. OGBUOJI O, Mao W, Aryeetey G
    The long-term impact of COVID-19 on development assistance for health is still uncertain.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01448.
    >> Share


  249. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990-2050.
    Lancet. 2021 Sep 22. pii: S0140-6736(21)01258.
    >> Share

  250. WU Z, Jin Q, Wu G, Lu J, et al
    SARS-CoV-2's origin should be investigated worldwide for pandemic prevention.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02020.
    >> Share

  251. VAN HELDEN J, Butler CD, Achaz G, Canard B, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02019.
    >> Share

  252. KEUSCH GT, Lam SK, Mackenzie JS, Saif L, et al
    An appeal for an objective, open, and transparent scientific debate about the origin of SARS-CoV-2 - Authors' reply.
    Lancet. 2021 Sep 17. pii: S0140-6736(21)02013.
    >> Share

  253. SHARFSTEIN JM, Callaghan T, Carpiano RM, Sgaier SK, et al
    Uncoupling vaccination from politics: a call to action.
    Lancet. 2021 Sep 16. pii: S0140-6736(21)02099.
    >> Share

  254. YOUNG BC, Eyre DW, Kendrick S, White C, et al
    Daily testing for contacts of individuals with SARS-CoV-2 infection and attendance and SARS-CoV-2 transmission in English secondary schools and colleges: an open-label, cluster-randomised trial.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)01908.
    >> Share

  255. KRAUSE PR, Fleming TR, Peto R, Longini IM, et al
    Considerations in boosting COVID-19 vaccine immune responses.
    Lancet. 2021 Sep 14. pii: S0140-6736(21)02046.
    >> Share

  256. LANE R
    Gagandeep Kang: helping to shape a healthier India.
    Lancet. 2021;398:947.
    >> Share

  257. DANIELS JP
    Earthquake compounds Haiti's health challenges.
    Lancet. 2021;398:944-945.
    >> Share

  258. MONTI M, Torbica A, Mossialos E, McKee M, et al
    A new strategy for health and sustainable development in the light of the COVID-19 pandemic.
    Lancet. 2021 Sep 9. pii: S0140-6736(21)01995.
    >> Share

  259. HARVEY SB, Epstein RM, Glozier N, Petrie K, et al
    Mental illness and suicide among physicians.
    Lancet. 2021;398:920-930.
    >> Share

  260. BOSELEY S
    The race to make a COVID-19 vaccine.
    Lancet. 2021;398:832-833.
    >> Share

  261. JERVING S
    The long road ahead for COVID-19 vaccination in Africa.
    Lancet. 2021;398:827-828.
    >> Share

  262. GAMALLIEL N, Saminarsih D, Taher A
    Indonesia's second wave crisis: medical doctors' political role is needed more than ever.
    Lancet. 2021;398:839-840.
    >> Share

  263. ROGAWSKI MCQUADE ET, Breskin A
    Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01817.
    >> Share

  264. KASEJE N, Walcott D
    Global youth advocating for COVID-19 vaccines for all.
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01994.
    >> Share

  265. FLAXMAN A, Marchevsky NG, Jenkin D, Aboagye J, et al
    Reactogenicity and immunogenicity after a late second dose or a third dose of ChAdOx1 nCoV-19 in the UK: a substudy of two randomised controlled trials (COV001 and COV002).
    Lancet. 2021 Sep 1. pii: S0140-6736(21)01699.
    >> Share

    August 2021
  266. HUANG L, Yao Q, Gu X, Wang Q, et al
    1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study.
    Lancet. 2021;398:747-758.
    >> Share

  267. THE LANCET
    Understanding long COVID: a modern medical challenge.
    Lancet. 2021;398:725.
    >> Share

  268. LANGLOIS EV, Dey T, Shah MG
    More than honour, humanitarian health-care workers need life-saving protection.
    Lancet. 2021;398:729-730.
    >> Share

  269. ZUNIGA JM, Russell A, Lusimbo R, Tshabalala S, et al
    The costs of PEPFAR's leadership vacuum.
    Lancet. 2021;398:741.
    >> Share

  270. LINDENFELD J, Zile MR, Desai AS, Bhatt K, et al
    Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01754.
    >> Share

  271. SOAR J, Becker LB, Berg KM, Einav S, et al
    Cardiopulmonary resuscitation in special circumstances.
    Lancet. 2021 Aug 26. pii: S0140-6736(21)01257.
    >> Share

  272. SALLES A, Jagsi R
    Institutional imperatives for the advancement of women in medicine and science through the COVID-19 pandemic.
    Lancet. 2021 Aug 24. pii: S0140-6736(21)01912.
    >> Share

  273. CONLY J, Chou R, Schwaber MJ, Voss A, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660.
    >> Share

  274. JUNI P, da Costa BR, Bobos P, Bodmer NS, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:663.
    >> Share

  275. CHU D, Khamis A, Akl E, Neumann I, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection - Authors' reply.
    Lancet. 2021;398:663-664.
    >> Share

  276. ZHOU Q, Wang X, Estill J, Yang K, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661.
    >> Share

  277. ABBAS M, Goto M, Tartari E, Perencevich E, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:661-663.
    >> Share

  278. SCORRANO L, Baglivo I, Cavallo DM, Cecconi F, et al
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:660-661.
    >> Share

  279. LIJFERING WM
    Revisiting the evidence for physical distancing, face masks, and eye protection.
    Lancet. 2021;398:659-660.
    >> Share

  280. COGHLAN R
    Broaden the narrative this World Humanitarian Day: honour those who comfort the dying.
    Lancet. 2021;398:659.
    >> Share

  281. ROCHON PA, Kalia S, Higgs P
    Gendered ageism: addressing discrimination based on age and sex.
    Lancet. 2021;398:648-649.
    >> Share

  282. ADEPOJU P
    West Africa on alert for haemorrhagic fevers.
    Lancet. 2021;398:653.
    >> Share

  283. USHER AD
    Health leaders criticise limited ACT-A review.
    Lancet. 2021;398:650-651.
    >> Share

  284. BEHRENS GM, Cossmann A, Stankov MV, Nehlmeier I, et al
    SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01891.
    >> Share


  285. Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019.
    Lancet. 2021 Aug 17. pii: S0140-6736(21)01207.
    >> Share

  286. THORNTON J
    Focusing on island health.
    Lancet. 2021;398:569-570.
    >> Share

  287. DANIELS JP
    Haiti's health woes intensify.
    Lancet. 2021;398:567.
    >> Share

  288. FRIEDEN TR, Lee CT, Bochner AF, Buissonniere M, et al
    7-1-7: an organising principle, target, and accountability metric to make the world safer from pandemics.
    Lancet. 2021;398:638-640.
    >> Share

  289. BHUYAN P, Medin J, da Silva HG, Yadavalli M, et al
    Very rare thrombosis with thrombocytopenia after second AZD1222 dose: a global safety database analysis.
    Lancet. 2021;398:577-578.
    >> Share

  290. BEHAGUE D, Ortega F
    Mutual aid, pandemic politics, and global social medicine in Brazil.
    Lancet. 2021;398:575-576.
    >> Share

  291. READ JM, Green CA, Harrison EM, Docherty AB, et al
    Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19 pandemic wave.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01786.
    >> Share

  292. CARR EJ, Wu M, Harvey R, Wall EC, et al
    Neutralising antibodies after COVID-19 vaccination in UK haemodialysis patients.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01854.
    >> Share

  293. ETIENNE CF
    Tackling Latin America's COVID-19 emergency requires greater solidarity.
    Lancet. 2021 Aug 12. pii: S0140-6736(21)01757.
    >> Share

  294. KALAFAT E, Magee LA, von Dadelszen P, O'Brien P, et al
    SARS-CoV-2 vaccination in pregnancy: a unique opportunity for equity.
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01756.
    >> Share

  295. LLOYD-SHERLOCK P, Lasco G, McKee M, Perianayagam A, et al
    Does vaccine ageism amount to gerontocide?
    Lancet. 2021 Aug 11. pii: S0140-6736(21)01689.
    >> Share

  296. PUNG R, Mak TM, Kucharski AJ, Lee VJ, et al
    Serial intervals in SARS-CoV-2 B.1.617.2 variant cases.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01697.
    >> Share

  297. MANGIN D, Howard M
    The use of inhaled corticosteroids in early-stage COVID-19.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01809.
    >> Share

  298. YU LM, Bafadhel M, Dorward J, Hayward G, et al
    Inhaled budesonide for COVID-19 in people at high risk of complications in the community in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Aug 10. pii: S0140-6736(21)01744.
    >> Share

  299. PRIESEMANN V, Balling R, Bauer S, Beutels P, et al
    Towards a European strategy to address the COVID-19 pandemic.
    Lancet. 2021 Aug 9. pii: S0140-6736(21)01808.
    >> Share

  300. BICCARD BM, Thomson D, Miller M, Taylor EH, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data - Authors' reply.
    Lancet. 2021;398:486-487.
    >> Share

  301. PISANI L, Waweru-Siika W, Sendagire C, Beane A, et al
    Critically ill COVID-19 patients in Africa: it is time for quality registry data.
    Lancet. 2021;398:485-486.
    >> Share

  302. DOLEZAL L, Rose A, Cooper F
    COVID-19, online shaming, and health-care professionals.
    Lancet. 2021;398:482-483.
    >> Share

  303. LEE N
    Lucy Chappell: setting the agenda for UK research policy.
    Lancet. 2021;398:481.
    >> Share

  304. DEVI S
    Mediterranean migrants lacking health care.
    Lancet. 2021;398:479-480.
    >> Share

  305. BLACK C
    Treatment for drug dependence in England needs investment and reform.
    Lancet. 2021;398:474-476.
    >> Share

  306. ROMANIS EC, Parsons JA, Salter I, Hampton T, et al
    Safeguarding and teleconsultation for abortion.
    Lancet. 2021;398:555-558.
    >> Share

  307. PERRY RJ, Tamborska A, Singh B, Craven B, et al
    Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01608.
    >> Share

  308. LIU X, Shaw RH, Stuart ASV, Greenland M, et al
    Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01694.
    >> Share

  309. BELDA-INIESTA C
    Optimising SARS-CoV-2 vaccination schedules.
    Lancet. 2021 Aug 6. pii: S0140-6736(21)01729.
    >> Share

  310. EMANUEL EJ, Buchanan A, Chan SY, Fabre C, et al
    What are the obligations of pharmaceutical companies in a global health emergency?
    Lancet. 2021 Aug 5. pii: S0140-6736(21)01378.
    >> Share

  311. CHAUHAN K, Soni D, Sarkar D, Karuna T, et al
    Mucormycosis after COVID-19 in a patient with diabetes.
    Lancet. 2021 Aug 4. pii: S0140-6736(21)01641.
    >> Share

    July 2021
  312. MATHUR R, Rentsch CT, Morton CE, Eggo RM, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease? - Authors' reply.
    Lancet. 2021;398:390.
    >> Share

  313. PAN D, Martin CA, Nazareth J, Nevill CR, et al
    Ethnic disparities in COVID-19: increased risk of infection or severe disease?
    Lancet. 2021;398:389-390.
    >> Share

  314. LURIE N, Keusch GT, Dzau VJ
    Should global financing be the main priority for pandemic preparedness? - Authors' reply.
    Lancet. 2021;398:388-389.
    >> Share

  315. SHROTRI M, Navaratnam AMD, Nguyen V, Byrne T, et al
    Spike-antibody waning after second dose of BNT162b2 or ChAdOx1.
    Lancet. 2021;398:385-387.
    >> Share

  316. THE LANCET
    A sporting chance: physical activity as part of everyday life.
    Lancet. 2021;398:365.
    >> Share

  317. KAMPMANN B, Okomo U
    COVID-19 vaccines for children in LMICs: another equity issue.
    Lancet. 2021 Jul 30. pii: S0140-6736(21)01748.
    >> Share

  318. KATSOULARIS I, Fonseca-Rodriguez O, Farrington P, Lindmark K, et al
    Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study.
    Lancet. 2021 Jul 29. pii: S0140-6736(21)00896.
    >> Share

  319. MAFHAM M, Baigent C
    What is the association of COVID-19 with heart attacks and strokes?
    Lancet. 2021 Jul 29. pii: S0140-6736(21)01071.
    >> Share

  320. HORBY P, Staplin N, Haynes R, Landray M, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how? - Authors' reply.
    Lancet. 2021;398:300.
    >> Share

  321. YANG C, Zhao H
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299.
    >> Share

  322. NEUMANN AU, Goekkaya M, Dorgham K, Traidl-Hoffmann C, et al
    Tocilizumab in COVID-19 therapy: who benefits, and how?
    Lancet. 2021;398:299-300.
    >> Share

  323. MARKS L
    Past and present women pioneers in biomedical science.
    Lancet. 2021;398:293-295.
    >> Share

  324. MAKONI M
    Social unrest disrupts South African health care.
    Lancet. 2021;398:287.
    >> Share

  325. REDJOUL R, Le Bouter A, Beckerich F, Fourati S, et al
    Antibody response after second BNT162b2 dose in allogeneic HSCT recipients.
    Lancet. 2021;398:298-299.
    >> Share

  326. THE LANCET
    A time of crisis for the opioid epidemic in the USA.
    Lancet. 2021;398:277.
    >> Share

  327. JAUREGUI A, Lambert EV, Panter J, Moore C, et al
    Scaling up urban infrastructure for physical activity in the COVID-19 pandemic and beyond.
    Lancet. 2021 Jul 21. pii: S0140-6736(21)01599.
    >> Share

  328. HILLIS SD, Unwin HJT, Chen Y, Cluver L, et al
    Global minimum estimates of children affected by COVID-19-associated orphanhood and deaths of caregivers: a modelling study.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01253.
    >> Share

  329. KENTOR RA, Thompson AL
    Answering the call to support youth orphaned by COVID-19.
    Lancet. 2021 Jul 20. pii: S0140-6736(21)01446.
    >> Share

  330. DRAKE TM, Riad AM, Fairfield CJ, Egan C, et al
    Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study.
    Lancet. 2021;398:223-237.
    >> Share

  331. HARGREAVES S, Hayward SE, Noori T, McKee M, et al
    COVID-19: counting migrants in.
    Lancet. 2021;398:211-212.
    >> Share

  332. GU X, Cao B
    In-hospital complications associated with COVID-19.
    Lancet. 2021;398:188-190.
    >> Share

  333. THE LANCET
    COVID-19 in Africa: a lesson in solidarity.
    Lancet. 2021;398:185.
    >> Share

  334. IDROVO AJ
    More social discontent than pandemic-related risk perception in Colombia.
    Lancet. 2021;398:211.
    >> Share

  335. FISSEHA S, Sen G, Ghebreyesus TA, Byanyima W, et al
    COVID-19: the turning point for gender equality.
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01651.
    >> Share

  336. HIAM L, Yates R
    Will the COVID-19 crisis catalyse universal health reforms?
    Lancet. 2021 Jul 16. pii: S0140-6736(21)01650.
    >> Share

  337. CAUCHEMEZ S, Bosetti P, Kiem CT, Mouro V, et al
    Education and mental health: good reasons to vaccinate children.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01453.
    >> Share

  338. CAUSEY K, Fullman N, Sorensen RJD, Galles NC, et al
    Estimating global and regional disruptions to routine childhood vaccine coverage during the COVID-19 pandemic in 2020: a modelling study.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01337.
    >> Share


  339. Measuring routine childhood vaccination coverage in 204 countries and territories, 1980-2019: a systematic analysis for the Global Burden of Disease Study 2020, Release 1.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)00984.
    >> Share

  340. ABBAS K, Mogasale V
    Disruptions to childhood immunisation due to the COVID-19 pandemic.
    Lancet. 2021 Jul 14. pii: S0140-6736(21)01418.
    >> Share

  341. THE LANCET
    COVID-19 in Latin America-emergency and opportunity.
    Lancet. 2021;398:93.
    >> Share

  342. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    WHO COVID-19 therapeutic guidelines - Authors' reply.
    Lancet. 2021;398:118.
    >> Share

  343. ROCHWERG B, Agoritsas T, Diaz J, Askie L, et al
    WHO COVID-19 therapeutic guidelines.
    Lancet. 2021;398:117-118.
    >> Share

  344. ALSABA K
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region.
    Lancet. 2021;398:116.
    >> Share

  345. NABETH P, Hassan M, Adib K, Abubakar A, et al
    Addressing the real trajectory of COVID-19 in the Eastern Mediterranean region - Authors' reply.
    Lancet. 2021;398:116-117.
    >> Share

  346. GARDNER C, Kleinman A
    Medicine and the unconscious.
    Lancet. 2021;398:112-113.
    >> Share

  347. LEHTIMAKI S, Allotey P, Schwalbe N
    Pandemic response requires early and robust verification.
    Lancet. 2021;398:115.
    >> Share

  348. TANRIOVER MD, Doganay HL, Akova M, Guner HR, et al
    Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in Turkey.
    Lancet. 2021 Jul 8. pii: S0140-6736(21)01429.
    >> Share

  349. GURDASANI D, Drury J, Greenhalgh T, Griffin S, et al
    Mass infection is not an option: we must do more to protect our young.
    Lancet. 2021 Jul 7. pii: S0140-6736(21)01589.
    >> Share

  350. CALISHER CH, Carroll D, Colwell R, Corley RB, et al
    Science, not speculation, is essential to determine how SARS-CoV-2 reached humans.
    Lancet. 2021 Jul 5. pii: S0140-6736(21)01419.
    >> Share

  351. PALMER KR, Tanner M, Davies-Tuck M, Rindt A, et al
    Widespread implementation of a low-cost telehealth service in the delivery of antenatal care during the COVID-19 pandemic: an interrupted time-series analysis.
    Lancet. 2021;398:41-52.
    >> Share

  352. CLARKE R
    Sparks through the stubble: dying in a pandemic.
    Lancet. 2021;398:18-19.
    >> Share

  353. THORNTON J
    Levelling up health in the UK.
    Lancet. 2021;398:14-15.
    >> Share

  354. DEVI S
    North Korean health at risk due to border closures.
    Lancet. 2021;398:13.
    >> Share

  355. THE LANCET
    Germany's election: transformation versus more of the same.
    Lancet. 2021;398:1.
    >> Share

  356. KICKBUSCH I, Leung GM, Shattock RJ
    Learning from crisis: building resilient systems to combat future pandemics.
    Lancet. 2021;398:e2-e6.
    >> Share

  357. MEYER NJ, Gattinoni L, Calfee CS
    Acute respiratory distress syndrome.
    Lancet. 2021 Jul 1. pii: S0140-6736(21)00439.
    >> Share

    June 2021
  358. WALL EC, Wu M, Harvey R, Kelly G, et al
    AZD1222-induced neutralising antibody activity against SARS-CoV-2 Delta VOC.
    Lancet. 2021 Jun 28. pii: S0140-6736(21)01462.
    >> Share

  359. KUMAR D, Mittal M
    India's COVID-19 emergency: overarching conclusions belie facts.
    Lancet. 2021;397:2465.
    >> Share

  360. SAHA K
    Can India's COVID-19 emergency be fixed without politics?
    Lancet. 2021;397:2465-2466.
    >> Share

  361. VISARIA A, Dharamdasani T
    The complex causes of India's 2021 COVID-19 surge.
    Lancet. 2021;397:2464.
    >> Share

  362. RADHAKRISHNAN N, Gupta DK
    India's COVID-19 response: science first.
    Lancet. 2021;397:2464-2465.
    >> Share

  363. DUTTA R, Kucchal T
    India's pain: beyond COVID-19 case numbers and mortality rates.
    Lancet. 2021;397:2463.
    >> Share

  364. DANIELS JP
    Colombians protest over inequities and health care.
    Lancet. 2021;397:2454.
    >> Share

  365. SMITH MJ
    What constitutes success in the roll-out of COVID-19 vaccines?
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01244.
    >> Share

  366. DUARTE-SALLES T, Prieto-Alhambra D
    Heterologous vaccine regimens against COVID-19.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01442.
    >> Share

  367. BOROBIA AM, Carcas AJ, Perez-Olmeda M, Castano L, et al
    Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial.
    Lancet. 2021 Jun 25. pii: S0140-6736(21)01420.
    >> Share

  368. THE LANCET
    Protecting refugees during the COVID-19 pandemic.
    Lancet. 2021;397:2309.
    >> Share

  369. BARRON GC, Koonin J
    A call to action on UHC commitments.
    Lancet. 2021;397:2335-2336.
    >> Share

  370. USHER AD
    A beautiful idea: how COVAX has fallen short.
    Lancet. 2021;397:2322-2325.
    >> Share

  371. KC S, Ananthakrishnan A, Painter C, Butani D, et al
    Research collaboration is needed to inform quarantine policies for health-care workers.
    Lancet. 2021;397:2334.
    >> Share

  372. ABECASSIS A
    Five priorities for universal COVID-19 vaccination.
    Lancet. 2021 Jun 17. pii: S0140-6736(21)01371.
    >> Share

  373. SHEIKH A, McMenamin J, Taylor B, Robertson C, et al
    SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness.
    Lancet. 2021 Jun 14. pii: S0140-6736(21)01358.
    >> Share

  374. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    COVID-19 vaccine efficacy data: solid enough to delay second dose? - Authors' reply.
    Lancet. 2021;397:2249-2250.
    >> Share

  375. ROBERTSON JFR, Sewell HF
    COVID-19 vaccine efficacy data: solid enough to delay second dose?
    Lancet. 2021;397:2248-2249.
    >> Share

  376. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates - Authors' reply.
    Lancet. 2021;397:2248.
    >> Share

  377. MCQUADE ETR, Platts-Mills JA
    ChAdOx1 nCoV-19 vaccine: asymptomatic efficacy estimates.
    Lancet. 2021;397:2247-2248.
    >> Share

  378. NASSER A, Zakham F
    A strategy for SARS-CoV-2 vaccination in Yemen.
    Lancet. 2021;397:2247.
    >> Share

  379. GUBRIUM A, Gubrium E
    Narrative complexity in the time of COVID-19.
    Lancet. 2021;397:2244-2245.
    >> Share

  380. BERGER JS, Connors JM
    Anticoagulation in COVID-19: reaction to the ACTION trial.
    Lancet. 2021;397:2226-2228.
    >> Share

  381. MCLELLAN F
    Kirsten Ostherr: mobilising the translational humanities.
    Lancet. 2021;397:2243.
    >> Share

  382. THE LANCET
    We need a global conversation on the 2020 Olympic Games.
    Lancet. 2021;397:2225.
    >> Share

  383. GUETL K, Gary T, Raggam RB, Schmid J, et al
    SARS-CoV-2 vaccine-induced immune thrombotic thrombocytopenia treated with immunoglobulin and argatroban.
    Lancet. 2021 Jun 11. pii: S0140-6736(21)01238.
    >> Share

  384. EVAGORA-CAMPBELL M, Borkotoky K, Sharma S, Mbuthia M, et al
    From routine data collection to policy design: sex and gender both matter in COVID-19.
    Lancet. 2021 Jun 10. pii: S0140-6736(21)01326.
    >> Share

  385. BOLLYKY TJ, Murray CJL, Reiner RC Jr
    Epidemiology, not geopolitics, should guide COVID-19 vaccine donations.
    Lancet. 2021 Jun 8. pii: S0140-6736(21)01323.
    >> Share

  386. KUMAR A, Bernasconi V, Manak M, de Almeida Aranha AP, et al
    The CEPI centralised laboratory network: supporting COVID-19 vaccine development.
    Lancet. 2021;397:2148-2149.
    >> Share

  387. ZAROCOSTAS J
    Aid agencies escalate Gaza relief effort.
    Lancet. 2021;397:2136.
    >> Share

  388. BEYRER C
    A pandemic anniversary: 40 years of HIV/AIDS.
    Lancet. 2021;397:2142-2143.
    >> Share

  389. SHROFF ZC, Marten R, Vega J, Peters DH, et al
    Time to reconceptualise health systems.
    Lancet. 2021;397:2145.
    >> Share

  390. USHER AD
    ACT Accelerator strains donors' aid budgets.
    Lancet. 2021;397:2137.
    >> Share

  391. CHAN EYY, Gobat N, Dubois C, Bedson J, et al
    Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01233.
    >> Share

  392. LOPES RD, de Barros E Silva PGM, Furtado RHM, Macedo AVS, et al
    Therapeutic versus prophylactic anticoagulation for patients admitted to hospital with COVID-19 and elevated D-dimer concentration (ACTION): an open-label, multicentre, randomised, controlled trial.
    Lancet. 2021 Jun 4. pii: S0140-6736(21)01203.
    >> Share

  393. WALL EC, Wu M, Harvey R, Kelly G, et al
    Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination.
    Lancet. 2021 Jun 3. pii: S0140-6736(21)01290.
    >> Share

  394. KOSAKA M, Hashimoto T, Ozaki A, Tanimoto T, et al
    Delayed COVID-19 vaccine roll-out in Japan.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01220.
    >> Share

  395. NNAJI CA, Ndwandwe D, Lesosky M, Mahomed H, et al
    Tackling missed opportunities for vaccination in a new era of immunisation.
    Lancet. 2021 Jun 2. pii: S0140-6736(21)01226.
    >> Share

  396. FORMAN R, Jit M, Mossialos E
    Divergent vaccination policies could fuel mistrust and hesitancy.
    Lancet. 2021 Jun 1. pii: S0140-6736(21)01106.
    >> Share

    May 2021
  397. MAKONI M
    Africa's need for more COVID-19 clinical trials.
    Lancet. 2021;397:2037.
    >> Share

  398. TATUM M
    Cambodia ends controversial COVID-19 restrictions.
    Lancet. 2021;397:2035.
    >> Share

  399. DEVI S
    Yemen's health system has "collapsed", warns UN.
    Lancet. 2021;397:2036.
    >> Share

  400. DEVI S
    800 000 South Sudanese to lose access to health care.
    Lancet. 2021;397:2034.
    >> Share

  401. AIYAR Y, Chandru V, Chatterjee M, Desai S, et al
    India's resurgence of COVID-19: urgent actions needed.
    Lancet. 2021 May 25. pii: S0140-6736(21)01202.
    >> Share


  402. Patient care and clinical outcomes for patients with COVID-19 infection admitted to African high-care or intensive care units (ACCCOS): a multicentre, prospective, observational cohort study.
    Lancet. 2021;397:1885-1894.
    >> Share

  403. JAWAD NK, Taweeleh LA, Elharake JA, Khamis N, et al
    Refugee access to COVID-19 vaccines in Lebanon.
    Lancet. 2021;397:1884.
    >> Share

  404. NESAMONEY SN, Darmstadt GL, Wise PH
    Gendered effects of COVID-19 on young girls in regions of conflict.
    Lancet. 2021;397:1880-1881.
    >> Share

  405. ZAROCOSTAS J
    What next for a COVID-19 intellectual property waiver?
    Lancet. 2021;397:1871-1872.
    >> Share

  406. KIRENGA BJ, Byakika-Kibwika P
    Excess COVID-19 mortality among critically ill patients in Africa.
    Lancet. 2021;397:1860-1861.
    >> Share

  407. MCGEORGE E, James J, Abraham N
    The intergenerational project: creating space for play in health care.
    Lancet. 2021;397:1876-1877.
    >> Share

  408. SAMARASEKERA U
    Yee-Sin Leo: a leader in Singapore's fight against infectious diseases.
    Lancet. 2021;397:1873.
    >> Share

  409. HUANG L, Gu X, Wang Y, Huang C, et al
    Long-term effects of COVID-19 on kidney function - Authors' reply.
    Lancet. 2021;397:1807-1808.
    >> Share

  410. LOYO ESL, Gonzalez MJ, Esparza J
    Venezuela is collapsing without COVID-19 vaccines.
    Lancet. 2021;397:1806.
    >> Share

  411. WATSON SI
    Global COVID-19 vaccine roll-out: time to randomise vaccine allocation?
    Lancet. 2021;397:1804-1805.
    >> Share

  412. GENC K
    COVID-19 in Turkey: a nation on edge.
    Lancet. 2021;397:1794-1796.
    >> Share

  413. DELANAYE P, Huart J, Bouquegneau A, Jouret F, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1807.
    >> Share

  414. ENGHARD P, Hardenberg JH, Stockmann H, Hinze C, et al
    Long-term effects of COVID-19 on kidney function.
    Lancet. 2021;397:1806-1807.
    >> Share

  415. HOUSTON AR, Murthy S
    Canada is no global health leader on COVID-19 vaccine equity.
    Lancet. 2021;397:1803.
    >> Share

  416. HOLT E
    Serbia begins paying citizens to receive a COVID-19 vaccine.
    Lancet. 2021;397:1793.
    >> Share

  417. WENHAM C, Kavanagh M, Phelan A, Rushton S, et al
    Problems with traffic light approaches to public health emergencies of international concern.
    Lancet. 2021;397:1856-1858.
    >> Share

  418. HIMMELSTEIN DU, Woolhandler S
    Recovering from Trump: Biden's first 100 days.
    Lancet. 2021;397:1787-1791.
    >> Share

  419. MORGAN OW, Aguilera X, Ammon A, Amuasi J, et al
    Disease surveillance for the COVID-19 era: time for bold changes.
    Lancet. 2021 May 14. pii: S0140-6736(21)01096.
    >> Share


  420. Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
    Lancet. 2021 May 14. pii: S0140-6736(21)00897.
    >> Share

  421. KUPPALLI K, Gala P, Cherabuddi K, Kalantri SP, et al
    India's COVID-19 crisis: a call for international action.
    Lancet. 2021 May 14. pii: S0140-6736(21)01121.
    >> Share

  422. LIU STH, Aberg JA
    Convalescent plasma in patients hospitalised with COVID-19.
    Lancet. 2021 May 14. pii: S0140-6736(21)01064.
    >> Share

  423. JHA P, Jamison DT, Watkins DA, Bell J, et al
    A global compact to counter vaccine nationalism.
    Lancet. 2021 May 14. pii: S0140-6736(21)01105.
    >> Share

  424. SHAW RH, Stuart A, Greenland M, Liu X, et al
    Heterologous prime-boost COVID-19 vaccination: initial reactogenicity data.
    Lancet. 2021 May 12. pii: S0140-6736(21)01115.
    >> Share

  425. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV
    Data discrepancies and substandard reporting of interim data of Sputnik V phase 3 trial - Authors' reply.
    Lancet. 2021 May 12. pii: S0140-6736(21)00894.
    >> Share

  426. SIRLEAF EJ, Clark H
    Report of the Independent Panel for Pandemic Preparedness and Response: making COVID-19 the last pandemic.
    Lancet. 2021 May 11. pii: S0140-6736(21)01095.
    >> Share

  427. MATHUR R, Rentsch CT, Morton CE, Hulme WJ, et al
    Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform.
    Lancet. 2021;397:1711-1724.
    >> Share

  428. MORALES DR, Ali SN
    COVID-19 and disparities affecting ethnic minorities.
    Lancet. 2021;397:1684-1685.
    >> Share

  429. FUJIWARA Y, Onda Y, Hayashi S
    No-fault compensation schemes for COVID-19 medical products.
    Lancet. 2021;397:1707-1708.
    >> Share

  430. SHAH W, Heightman M, O'Brien S
    UK guidelines for managing long-term effects of COVID-19.
    Lancet. 2021;397:1706.
    >> Share

  431. THE LANCET
    India's COVID-19 emergency.
    Lancet. 2021;397:1683.
    >> Share

  432. HE S, Bala R, Anupindi R, Ranney ML, et al
    Effective supply chain surveillance for PPE.
    Lancet. 2021;397:1706-1707.
    >> Share

  433. DEVI S
    COVID-19 surge threatens health in the Gaza strip.
    Lancet. 2021;397:1698.
    >> Share

  434. SAXENA SG, Godfrey T
    Catalysing needed change for health systems in the USA.
    Lancet. 2021;397:1705-1706.
    >> Share

  435. NASAR S
    Patrolling race and the UK's medical borders.
    Lancet. 2021;397:1702-1703.
    >> Share

  436. ZAROCOSTAS J
    UK makes massive global health cuts.
    Lancet. 2021;397:1697.
    >> Share

  437. HOLT E
    Media restrictions have "cost lives".
    Lancet. 2021;397:1695-1696.
    >> Share

  438. RICHTER L, Ghent L, Issa G, Okengo L, et al
    What the ODA cuts mean for us.
    Lancet. 2021;397:1705.
    >> Share

  439. REINHART E, Dawes D, Maybank A
    Structural medicine: towards an economy of care.
    Lancet. 2021;397:1691-1693.
    >> Share

  440. KIDD SA, Hajat S, Bezgrebelna M, McKenzie K, et al
    The climate change-homelessness nexus.
    Lancet. 2021;397:1693-1694.
    >> Share


  441. Priorities for COVID-19 research response and preparedness in low-resource settings.
    Lancet. 2021 May 6. pii: S0140-6736(21)00980.
    >> Share

  442. MCKEE M, Dunnell K, Anderson M, Brayne C, et al
    The changing health needs of the UK population.
    Lancet. 2021 May 6. pii: S0140-6736(21)00229.
    >> Share

  443. ANDERSON M, Pitchforth E, Asaria M, Brayne C, et al
    LSE-Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19.
    Lancet. 2021 May 6. pii: S0140-6736(21)00232.
    >> Share

  444. CHARLESWORTH A, Anderson M, Donaldson C, Johnson P, et al
    What is the right level of spending needed for health and care in the UK?
    Lancet. 2021 May 6. pii: S0140-6736(21)00230.
    >> Share

  445. ANDERSON M, O'Neill C, Macleod Clark J, Street A, et al
    Securing a sustainable and fit-for-purpose UK health and care workforce.
    Lancet. 2021 May 6. pii: S0140-6736(21)00231.
    >> Share

  446. HAAS EJ, Angulo FJ, McLaughlin JM, Anis E, et al
    Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Lancet. 2021 May 5. pii: S0140-6736(21)00947.
    >> Share

  447. LESHEM E, Wilder-Smith A
    COVID-19 vaccine impact in Israel and a way out of the pandemic.
    Lancet. 2021 May 5. pii: S0140-6736(21)01018.
    >> Share


  448. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021;397:1637-1645.
    >> Share

  449. BHUYAN A
    Experts criticise India's complacency over COVID-19.
    Lancet. 2021;397:1611-1612.
    >> Share

  450. GUPTA S, Leaf DE
    Tocilizumab in COVID-19: some clarity amid controversy.
    Lancet. 2021;397:1599-1601.
    >> Share

  451. FOGSTAD H
    Women, children, and adolescents in the post-pandemic world.
    Lancet. 2021;397:1620.
    >> Share

  452. HYDE R
    Controversy surrounds Merkel's new lockdown powers.
    Lancet. 2021;397:1610.
    >> Share

    April 2021
  453. OLIU-BARTON M, Pradelski BSR, Aghion P, Artus P, et al
    SARS-CoV-2 elimination, not mitigation, creates best outcomes for health, the economy, and civil liberties.
    Lancet. 2021 Apr 28. pii: S0140-6736(21)00978.
    >> Share

  454. MAGNAVITA N, Chirico F, Sacco A
    COVID-19: from hospitals to courts.
    Lancet. 2021;397:1542.
    >> Share

  455. USUELLI M
    COVID-19: from hospitals to courts - Author's reply.
    Lancet. 2021;397:1542.
    >> Share

  456. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Call for a pan-European COVID-19 response must be comprehensive - Authors' reply.
    Lancet. 2021;397:1541.
    >> Share

  457. KRUGER C
    Call for a pan-European COVID-19 response must be comprehensive.
    Lancet. 2021;397:1540-1541.
    >> Share

  458. BURKI T
    Statelessness in the COVID-19 pandemic.
    Lancet. 2021;397:1529-1530.
    >> Share

  459. THE LANCET
    2021: the beginning of a new era of immunisations?
    Lancet. 2021;397:1519.
    >> Share

  460. MARMOT M, Al-Mandhari A, Ghaffar A, El-Adawy M, et al
    Build back fairer: achieving health equity in the Eastern Mediterranean region of WHO.
    Lancet. 2021;397:1527-1528.
    >> Share

  461. RASANATHAN K
    Global health and its discontents.
    Lancet. 2021;397:1543-1544.
    >> Share

  462. HALL VJ, Foulkes S, Saei A, Andrews N, et al
    COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): a prospective, multicentre, cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00790.
    >> Share

  463. DEAN N
    Hospital admissions due to COVID-19 in Scotland after one dose of vaccine.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00765.
    >> Share

  464. VASILEIOU E, Simpson CR, Shi T, Kerr S, et al
    Interim findings from first-dose mass COVID-19 vaccination roll-out and COVID-19 hospital admissions in Scotland: a national prospective cohort study.
    Lancet. 2021 Apr 23. pii: S0140-6736(21)00677.
    >> Share

  465. KHAN MS, Ali SAM, Adelaine A, Karan A, et al
    Rethinking vaccine hesitancy among minority groups.
    Lancet. 2021 Apr 21. pii: S0140-6736(21)00938.
    >> Share

  466. CLAESON M, Hanson S
    The Swedish COVID-19 strategy revisited.
    Lancet. 2021 Apr 19. pii: S0140-6736(21)00885.
    >> Share

  467. ALVES L
    Brazilian ICUs short of drugs and beds amid COVID-19 surge.
    Lancet. 2021;397:1431-1432.
    >> Share

  468. STOEKLE HC, Ivasilevitch A, Herve C
    COVID-19: time for ethical reflection?
    Lancet. 2021 Apr 16. pii: S0140-6736(21)00795.
    >> Share

  469. GREENHALGH T, Jimenez JL, Prather KA, Tufekci Z, et al
    Ten scientific reasons in support of airborne transmission of SARS-CoV-2.
    Lancet. 2021 Apr 15. pii: S0140-6736(21)00869.
    >> Share

  470. KADIWAR S, Smith JJ, Ledot S, Johnson M, et al
    Were pregnant women more affected by COVID-19 in the second wave of the pandemic?
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00716.
    >> Share

  471. BAYAS A, Menacher M, Christ M, Behrens L, et al
    Bilateral superior ophthalmic vein thrombosis, ischaemic stroke, and immune thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00872.
    >> Share

  472. MFINANGA SG, Mnyambwa NP, Minja DT, Ntinginya NE, et al
    Tanzania's position on the COVID-19 pandemic.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00678.
    >> Share

  473. MUSTER V, Gary T, Raggam RB, WOlfler A, et al
    Pulmonary embolism and thrombocytopenia following ChAdOx1 vaccination.
    Lancet. 2021 Apr 14. pii: S0140-6736(21)00871.
    >> Share

  474. ZAROCOSTAS J
    Calls for transparency after SARS-CoV-2 origins report.
    Lancet. 2021;397:1335.
    >> Share

  475. THE LANCET
    China's response to COVID-19: a chance for collaboration.
    Lancet. 2021;397:1325.
    >> Share

  476. CAPUA I, Giaquinto C
    The unsung virtue of thermostability.
    Lancet. 2021;397:1346.
    >> Share

  477. CASSAN J, Claude A, de Hillerin M, Fontaine A, et al
    The ultra-connected generation would like to disconnect now.
    Lancet. 2021;397:1350.
    >> Share

  478. ANDREWS K
    Racism is the public health crisis.
    Lancet. 2021;397:1342-1343.
    >> Share

  479. KRAMMER F
    Correlates of protection from SARS-CoV-2 infection.
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00782.
    >> Share

  480. HALL VJ, Foulkes S, Charlett A, Atti A, et al
    SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Lancet. 2021 Apr 9. pii: S0140-6736(21)00675.
    >> Share

  481. LI L, Wang K, Chen Z, Koplan JP, et al
    US-China health exchange and collaboration following COVID-19.
    Lancet. 2021 Apr 8. pii: S0140-6736(21)00734.
    >> Share

  482. ALI SN, Hanif W, Patel K, Khunti K, et al
    Ramadan and COVID-19 vaccine hesitancy-a call for action.
    Lancet. 2021 Apr 7. pii: S0140-6736(21)00779.
    >> Share

  483. SALYER SJ, Maeda J, Sembuche S, Kebede Y, et al
    The first and second waves of the COVID-19 pandemic in Africa: a cross-sectional study.
    Lancet. 2021;397:1265-1275.
    >> Share

  484. LOTTA G, Fernandez M, Pimenta D, Wenham C, et al
    Gender, race, and health workers in the COVID-19 pandemic.
    Lancet. 2021;397:1264.
    >> Share

  485. BOUM Y, Bebell LM, Bisseck AZ
    Africa needs local solutions to face the COVID-19 pandemic.
    Lancet. 2021;397:1238-1240.
    >> Share

  486. WONG CHUNG JERE, Engin O, Wolfs TFW, Renson TJC, et al
    Anterior uveitis in paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2.
    Lancet. 2021;397:e10.
    >> Share

  487. BOJORQUEZ I, Cabieses B, Arosquipa C, Arroyo J, et al
    Migration and health in Latin America during the COVID-19 pandemic and beyond.
    Lancet. 2021;397:1243-1245.
    >> Share

  488. HE S, Lai D, Lee J
    The medical right to repair: the right to save lives.
    Lancet. 2021;397:1260-1261.
    >> Share

  489. SAMARASEKERA U
    New EU health programme comes into force.
    Lancet. 2021;397:1252-1253.
    >> Share

  490. JABBOUR S, Leaning J, Nuwayhid I, Ager A, et al
    10 years of the Syrian conflict: a time to act and not merely to remember.
    Lancet. 2021;397:1245-1248.
    >> Share

  491. D'SOUZA RS, Wolfe I
    COVID-19 vaccines in high-risk ethnic groups.
    Lancet. 2021 Apr 1. pii: S0140-6736(21)00624.
    >> Share

    March 2021
  492. EMARY KRW, Golubchik T, Aley PK, Ariani CV, et al
    Efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine against SARS-CoV-2 variant of concern 202012/01 (B.1.1.7): an exploratory analysis of a randomised controlled trial.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00628.
    >> Share

  493. OSTERGAARD SD, Schmidt M, Horvath-Puho E, Thomsen RW, et al
    Thromboembolism and the Oxford-AstraZeneca COVID-19 vaccine: side-effect or coincidence?
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00762.
    >> Share

  494. SANDERS RW, de Jong MD
    Pandemic moves and countermoves: vaccines and viral variants.
    Lancet. 2021 Mar 30. pii: S0140-6736(21)00730.
    >> Share

  495. MYLAN S, Hardman C
    COVID-19, cults, and the anti-vax movement.
    Lancet. 2021;397:1181.
    >> Share

  496. USHER AD
    Uncertainties over EU COVID-19 vaccine sharing scheme.
    Lancet. 2021;397:1171.
    >> Share

  497. THE LANCET
    COVID-19: building a stronger Europe.
    Lancet. 2021;397:1157.
    >> Share

  498. HIPGRAVE DB, Kampo A, Pearson L
    Health systems in the ACT-A.
    Lancet. 2021;397:1181-1182.
    >> Share

  499. KLUGE H, McKee M
    COVID-19 vaccines for the European region: an unprecedented challenge.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00709.
    >> Share

  500. NABETH P, Hassan M, Adib K, Abubakar A, et al
    New COVID-19 resurgence in the WHO Eastern Mediterranean region.
    Lancet. 2021 Mar 25. pii: S0140-6736(21)00679.
    >> Share


  501. Human rights and fair access to COVID-19 vaccines: the International AIDS Society-Lancet Commission on Health and Human Rights.
    Lancet. 2021 Mar 24. pii: S0140-6736(21)00708.
    >> Share

  502. KRISTIANSEN PA, Page M, Bernasconi V, Mattiuzzo G, et al
    WHO International Standard for anti-SARS-CoV-2 immunoglobulin.
    Lancet. 2021 Mar 23. pii: S0140-6736(21)00527.
    >> Share

  503. MUNDT AP
    Assessing government responsibility for COVID-19 deaths.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00529.
    >> Share

  504. WHITE NJ, Strub-Wourgaft N, Faiz A, Guerin PJ, et al
    Guidelines should not pool evidence from uncomplicated and severe COVID-19.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00469.
    >> Share

  505. KARIM SSA
    Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00468.
    >> Share

  506. CHAKRABORTY D, Agrawal A, Maiti S
    Rapid identification and tracking of SARS-CoV-2 variants of concern.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00470.
    >> Share

  507. NKEREUWEM E, Kampmann B, Togun T
    The need to prioritise childhood tuberculosis case detection.
    Lancet. 2021 Mar 22. pii: S0140-6736(21)00672.
    >> Share

  508. HE Z, Ren L, Yang J, Guo L, et al
    Seroprevalence and humoral immune durability of anti-SARS-CoV-2 antibodies in Wuhan, China: a longitudinal, population-level, cross-sectional study.
    Lancet. 2021;397:1075-1084.
    >> Share

  509. JAFFE S
    Biden's first legislative victory: $1.9 trillion for COVID-19.
    Lancet. 2021;397:1047-1048.
    >> Share

  510. STRUGNELL R, Wang N
    Sustained neutralising antibodies in the Wuhan population suggest durable protection against SARS-CoV-2.
    Lancet. 2021;397:1037-1039.
    >> Share

  511. GILL PS, Poduval S, Thakur JS, Iqbal R, et al
    COVID-19, community trials, and inclusion.
    Lancet. 2021;397:1036-1037.
    >> Share

  512. CRISP N
    Human flourishing in a health-creating society.
    Lancet. 2021;397:1054-1055.
    >> Share

  513. THE LANCET
    Myanmar's democracy and health on life support.
    Lancet. 2021;397:1035.
    >> Share

  514. BOZORGMEHR K, Jahn R, Stuckler D, McKee M, et al
    Free licensing of vaccines to end the COVID-19 crisis.
    Lancet. 2021 Mar 18. pii: S0140-6736(21)00467.
    >> Share

  515. HANSEN CH, Michlmayr D, Gubbels SM, Molbak K, et al
    Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00575.
    >> Share

  516. TURNER P, Montgomery H, Stroud M, Grimble G, et al
    Malnutrition risk in hospitalised COVID-19 patients receiving CPAP.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00447.
    >> Share

  517. BOYTON RJ, Altmann DM
    Risk of SARS-CoV-2 reinfection after natural infection.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00662.
    >> Share

  518. KRIEGER N, Waterman PD, Chen JT, Testa C, et al
    Missing again: US racial and ethnic data for COVID-19 vaccination.
    Lancet. 2021 Mar 17. pii: S0140-6736(21)00465.
    >> Share

  519. SHAKESPEARE T, Ndagire F, Seketi QE
    Triple jeopardy: disabled people and the COVID-19 pandemic.
    Lancet. 2021 Mar 16. pii: S0140-6736(21)00625.
    >> Share

  520. HOLT E
    Countries split from EU on COVID-19 vaccines.
    Lancet. 2021;397:958.
    >> Share

  521. THE LANCET
    Access to COVID-19 vaccines: looking beyond COVAX.
    Lancet. 2021;397:941.
    >> Share

  522. AUCOTT JN, Rebman AW
    Long-haul COVID: heed the lessons from other infection-triggered illnesses.
    Lancet. 2021;397:967-968.
    >> Share

  523. COUSINS S
    Australian Commission calls for overhaul of aged care.
    Lancet. 2021;397:957.
    >> Share

  524. DEVI S
    Health in Syria: a decade of conflict.
    Lancet. 2021;397:955-956.
    >> Share

  525. WILLIAMS R, Alessi C, Alexander G, Allison M, et al
    New dimensions for hospital services and early detection of disease: a Review from the Lancet Commission into liver disease in the UK.
    Lancet. 2021 Mar 10. pii: S0140-6736(20)32396.
    >> Share

  526. GURDASANI D, Alwan NA, Greenhalgh T, Hyde Z, et al
    School reopening without robust COVID-19 mitigation risks accelerating the pandemic.
    Lancet. 2021 Mar 10. pii: S0140-6736(21)00622.
    >> Share

  527. LURIE N, Keusch GT, Dzau VJ
    Urgent lessons from COVID 19: why the world needs a standing, coordinated system and sustainable financing for global research and development.
    Lancet. 2021 Mar 9. pii: S0140-6736(21)00503.
    >> Share

  528. STEINBERG J, Thomas A, Iravani A
    (18)Fluorodeoxyglucose PET/CT findings in a systemic inflammatory response syndrome after COVID-19 vaccine.
    Lancet. 2021 Mar 8. pii: S0140-6736(21)00464.
    >> Share

  529. USHER AD
    Medical oxygen crisis: a belated COVID-19 response.
    Lancet. 2021;397:868-869.
    >> Share

  530. HUNG IFN, Poland GA
    Single-dose Oxford-AstraZeneca COVID-19 vaccine followed by a 12-week booster.
    Lancet. 2021;397:854-855.
    >> Share

  531. SAMARASEKERA U
    Robin Shattock: novel vaccine developer.
    Lancet. 2021;397:870.
    >> Share

  532. SROUR SA
    Social action to achieve a dignified life for people with disabilities in the occupied Palestinian territory.
    Lancet. 2021;397:861-862.
    >> Share

  533. SOE ZW, Oo MM, Wah KS, Naing AT, et al
    Myanmar's health leaders stand against military rule.
    Lancet. 2021;397:875.
    >> Share

  534. HEIDKAMP RA, Piwoz E, Gillespie S, Keats EC, et al
    Mobilising evidence, data, and resources to achieve global maternal and child undernutrition targets and the Sustainable Development Goals: an agenda for action.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00568.
    >> Share

  535. VICTORA CG, Christian P, Vidaletti LP, Gatica-Dominguez G, et al
    Revisiting maternal and child undernutrition in low-income and middle-income countries: variable progress towards an unfinished agenda.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00394.
    >> Share

  536. MADAD S, Spencer C
    The USA's response to the 2014 Ebola outbreak could have informed its COVID-19 response.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00433.
    >> Share

  537. VIJAYASINGHAM L, Bischof E, Wolfe J
    Sex-disaggregated data in COVID-19 vaccine trials.
    Lancet. 2021 Mar 5. pii: S0140-6736(21)00384.
    >> Share


  538. Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial.
    Lancet. 2021 Mar 4. pii: S0140-6736(21)00461.
    >> Share

    February 2021
  539. BATNIJI R
    Historical evidence to inform COVID-19 vaccine mandates.
    Lancet. 2021;397:791.
    >> Share

  540. CHAUVIN L
    Peruvian COVID-19 vaccine scandal spreads.
    Lancet. 2021;397:783.
    >> Share

  541. ZAROCOSTAS J
    New WTO leader faces COVID-19 challenges.
    Lancet. 2021;397:782.
    >> Share

  542. PEYRE M, Vourc'h G, Lefrancois T, Martin-Prevel Y, et al
    PREZODE: preventing zoonotic disease emergence.
    Lancet. 2021;397:792-793.
    >> Share

  543. SHAHRIZAILA N, Lehmann HC, Kuwabara S
    Guillain-Barre syndrome.
    Lancet. 2021 Feb 26. pii: S0140-6736(21)00517.
    >> Share

  544. MANISTY C, Otter AD, Treibel TA, McKnight A, et al
    Antibody response to first BNT162b2 dose in previously SARS-CoV-2-infected individuals.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00501.
    >> Share

  545. PRENDECKI M, Clarke C, Brown J, Cox A, et al
    Effect of previous SARS-CoV-2 infection on humoral and T-cell responses to single-dose BNT162b2 vaccine.
    Lancet. 2021 Feb 25. pii: S0140-6736(21)00502.
    >> Share

  546. WHITAKER DK
    UK COVID-19 public inquiry and lessons from patient safety.
    Lancet. 2021 Feb 24. pii: S0140-6736(21)00381.
    >> Share

  547. GODDARD AF, Patel M
    The changing face of medical professionalism and the impact of COVID-19.
    Lancet. 2021 Feb 23. pii: S0140-6736(21)00436.
    >> Share

  548. SIVA N
    Severe mental illness: reassessing COVID-19 vaccine priorities.
    Lancet. 2021;397:657.
    >> Share

  549. HYDE R
    von der Leyen admits to COVID-19 vaccine failures.
    Lancet. 2021;397:655-656.
    >> Share

  550. MMONU NA, Aifah A, Onakomaiya D, Ogedegbe G, et al
    Why the global health community should support the EndSARS movement in Nigeria.
    Lancet. 2021;397:666-667.
    >> Share

  551. DAS P
    Sharrelle Barber: at the intersection of place, race, and health.
    Lancet. 2021;397:659.
    >> Share

  552. THE LANCET
    Health in the USA: under examination and under repair.
    Lancet. 2021;397:641.
    >> Share

  553. VOYSEY M, Costa Clemens SA, Madhi SA, Weckx LY, et al
    Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00432.
    >> Share

  554. SISA I, Noblecilla E, Orozco F
    Rationale to continue approving placebo-controlled COVID-19 vaccine trials in LMICs.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00357.
    >> Share

  555. BERK J, Brinkley-Rubinstein L, Murphy M, Chan P, et al
    MAb for symptomatic COVID-19 in correctional facilities: an important opportunity.
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00354.
    >> Share

  556. ROBERTSON JFR, Sewell HF, Stewart M
    Delayed second dose of the BNT162b2 vaccine: innovation or misguided conjecture?
    Lancet. 2021 Feb 19. pii: S0140-6736(21)00455.
    >> Share

  557. FIELDS EL, Copeland R, Hopkins E
    Same script, different viruses: HIV and COVID-19 in US Black communities.
    Lancet. 2021 Feb 18. pii: S0140-6736(20)32522.
    >> Share

  558. BEYRER C, Adimora AA, Hodder SL, Hopkins E, et al
    Call to action: how can the US Ending the HIV Epidemic initiative succeed?
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00390.
    >> Share

  559. AMIT S, Regev-Yochay G, Afek A, Kreiss Y, et al
    Early rate reductions of SARS-CoV-2 infection and COVID-19 in BNT162b2 vaccine recipients.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00448.
    >> Share

  560. KATES J, Dawson L, Horn TH, Killelea A, et al
    Insurance coverage and financing landscape for HIV treatment and prevention in the USA.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00397.
    >> Share

  561. MAYER KH, Nelson L, Hightow-Weidman L, Mimiaga MJ, et al
    The persistent and evolving HIV epidemic in American men who have sex with men.
    Lancet. 2021 Feb 18. pii: S0140-6736(21)00321.
    >> Share

  562. MINA MJ, Peto TE, Garcia-Finana M, Semple MG, et al
    Clarifying the evidence on SARS-CoV-2 antigen rapid tests in public health responses to COVID-19.
    Lancet. 2021 Feb 17. pii: S0140-6736(21)00425.
    >> Share

  563. SKEGG D, Gluckman P, Boulton G, Hackmann H, et al
    Future scenarios for the COVID-19 pandemic.
    Lancet. 2021 Feb 16. pii: S0140-6736(21)00424.
    >> Share

  564. DALL'ALBA R, Rocha CF, de Pinho Silveira R, da Silva Costa Dresch L, et al
    COVID-19 in Brazil: far beyond biopolitics.
    Lancet. 2021;397:579-580.
    >> Share

  565. MAKONI M
    Tanzania refuses COVID-19 vaccines.
    Lancet. 2021;397:566.
    >> Share

  566. BERWANGER O
    Azithromycin, RECOVERY, and the power of large, simple trials.
    Lancet. 2021;397:559-560.
    >> Share

  567. SIVA N
    New global initiative to tackle Alzheimer's disease.
    Lancet. 2021;397:568-569.
    >> Share

  568. SINGH NS, Lokot M, Undie CC, Onyango MA, et al
    Research in forced displacement: guidance for a feminist and decolonial approach.
    Lancet. 2021;397:560-562.
    >> Share

  569. THE LANCET
    Improving prisoner health for stronger public health.
    Lancet. 2021;397:555.
    >> Share


  570. Priorities for the COVID-19 pandemic at the start of 2021: statement of the Lancet COVID-19 Commission.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00388.
    >> Share

  571. WOUTERS OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, et al
    Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
    Lancet. 2021 Feb 12. pii: S0140-6736(21)00306.
    >> Share

  572. FONTANET A, Autran B, Lina B, Kieny MP, et al
    SARS-CoV-2 variants and ending the COVID-19 pandemic.
    Lancet. 2021 Feb 11. pii: S0140-6736(21)00370.
    >> Share

  573. MARTIN S, Arawi T
    Ensure Palestinians have access to COVID-19 vaccines.
    Lancet. 2021 Feb 9. pii: S0140-6736(21)00190.
    >> Share

  574. BURKI T
    Understanding variants of SARS-CoV-2.
    Lancet. 2021;397:462.
    >> Share

  575. ZAROCOSTAS J
    WHO team begins COVID-19 origin investigation.
    Lancet. 2021;397:459.
    >> Share

  576. HORTON R
    Offline: COVID-19 and the convergence of nations.
    Lancet. 2021;397:458.
    >> Share

  577. GORNA R, MacDermott N, Rayner C, O'Hara M, et al
    Long COVID guidelines need to reflect lived experience.
    Lancet. 2021;397:455-457.
    >> Share

  578. BEHRENS RH, Patel V
    Avoiding shoulder injury from intramuscular vaccines.
    Lancet. 2021;397:471.
    >> Share

  579. WARRELL MJ
    Time to revise the strategy for Gavi funding of rabies vaccine?
    Lancet. 2021;397:471-472.
    >> Share

  580. LANE R
    Tahmeed Ahmed: new leader of icddr,b.
    Lancet. 2021;397:463.
    >> Share

  581. THE LANCET
    Genomic sequencing in pandemics.
    Lancet. 2021;397:445.
    >> Share

  582. CLARFIELD AM, Skorecki K, Manor O, Glick S, et al
    A COVID-19 jab in the right direction.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00310.
    >> Share

  583. KAMPF G, Kulldorff M
    Calling for benefit-risk evaluations of COVID-19 control measures.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00193.
    >> Share

  584. LOIZIDES U, Adisa A, de la Rica Manjavacas AL, Robertson JS, et al
    WHO international non-proprietary names: the need to distinguish COVID-19 vaccines.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00099.
    >> Share

  585. MEREWOOD A, Bode L, Davanzo R, Perez-Escamilla R, et al
    Breastfeed or be vaccinated-an unreasonable default recommendation.
    Lancet. 2021 Feb 4. pii: S0140-6736(21)00197.
    >> Share

  586. JONES I, Roy P
    Sputnik V COVID-19 vaccine candidate appears safe and effective.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00191.
    >> Share


  587. Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00149.
    >> Share

  588. LOGUNOV DY, Dolzhikova IV, Shcheblyakov DV, Tukhvatulin AI, et al
    Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia.
    Lancet. 2021 Feb 2. pii: S0140-6736(21)00234.
    >> Share

  589. FRIESEN P, Caplan AL, Miller JE
    COVID-19 vaccine research and the trouble with clinical equipoise.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00198.
    >> Share

  590. TUYISENGE G, Goldenberg SM
    COVID-19, structural racism, and migrant health in Canada.
    Lancet. 2021 Feb 1. pii: S0140-6736(21)00215.
    >> Share

    January 2021
  591. MUGUNGA JC, Tyagi K, Bernal-Serrano D, Correa N, et al
    SARS-CoV-2 serosurveys in low-income and middle-income countries.
    Lancet. 2021;397:353-355.
    >> Share

  592. SAMARASEKERA U
    Fransisca Handy Agung: improving adolescent health in Indonesia.
    Lancet. 2021;397:365.
    >> Share

  593. DANIELS JP
    Health experts slam Bolsonaro's vaccine comments.
    Lancet. 2021;397:361.
    >> Share

  594. THE LANCET
    Health and care workers are owed a better future.
    Lancet. 2021;397:347.
    >> Share

  595. HALLAL PC
    SOS Brazil: science under attack.
    Lancet. 2021;397:373-374.
    >> Share

  596. BLAKNEY AK, McKay PF
    Next-generation COVID-19 vaccines: here come the proteins.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00258.
    >> Share

  597. RICHMOND P, Hatchuel L, Dong M, Ma B, et al
    Safety and immunogenicity of S-Trimer (SCB-2019), a protein subunit vaccine candidate for COVID-19 in healthy adults: a phase 1, randomised, double-blind, placebo-controlled trial.
    Lancet. 2021 Jan 29. pii: S0140-6736(21)00241.
    >> Share


  598. Urgent needs of low-income and middle-income countries for COVID-19 vaccines and therapeutics.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00242.
    >> Share

  599. WATT G, Giacaman R, Zurayk H, Bjertness E, et al
    COVID-19 vaccines for Palestinians.
    Lancet. 2021 Jan 28. pii: S0140-6736(21)00185.
    >> Share

  600. SABINO EC, Buss LF, Carvalho MPS, Prete CA Jr, et al
    Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence.
    Lancet. 2021 Jan 27. pii: S0140-6736(21)00183.
    >> Share

  601. BARDAJI A, Sevene E, Cutland C, Menendez C, et al
    The need for a global COVID-19 maternal immunisation research plan.
    Lancet. 2021 Jan 25. pii: S0140-6736(21)00146.
    >> Share

  602. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Neuropathology associated with SARS-CoV-2 infection - Authors' reply.
    Lancet. 2021;397:277-278.
    >> Share

  603. NASRALLAH MP, Mourelatos Z, Lee EB
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:277.
    >> Share

  604. GLATZEL M, Hagel C, Matschke J, Sperhake J, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276.
    >> Share

  605. EGERVARI K, Thomas C, Lobrinus JA, Kuhlmann T, et al
    Neuropathology associated with SARS-CoV-2 infection.
    Lancet. 2021;397:276-277.
    >> Share

  606. AGIUS RM, Kendrick D, Sewell HF, Stewart M, et al
    Reaffirming health and safety precautionary principles for COVID-19 in the UK.
    Lancet. 2021;397:274.
    >> Share

  607. MAKONI M
    South Africa responds to new SARS-CoV-2 variant.
    Lancet. 2021;397:267.
    >> Share

  608. BHUYAN A
    India begins COVID-19 vaccination amid trial allegations.
    Lancet. 2021;397:264.
    >> Share

  609. THE LANCET
    COVID-19: the intersection of education and health.
    Lancet. 2021;397:253.
    >> Share

  610. MARCHALIK D, Lipsky A
    Transformative experiences and A Young Doctor's Notebook.
    Lancet. 2021;397:270.
    >> Share

  611. USHER AD
    CEPI criticised for lack of transparency.
    Lancet. 2021;397:265-266.
    >> Share

  612. JAFFE S
    Rochelle Walensky: new Director of the US CDC.
    Lancet. 2021;397:268.
    >> Share

  613. LAU E, Wang HH, Qiao J, Jiang B, et al
    Wakley-Wu Lien Teh Prize Essay 2020: passing the baton to the next generation of health workers.
    Lancet. 2021;397:261-262.
    >> Share

  614. WISE PH, Shiel A, Southard N, Bendavid E, et al
    The political and security dimensions of the humanitarian health response to violent conflict.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00130.
    >> Share

  615. PATEL MS, Phillips CB
    COVID-19 and the moral imagination.
    Lancet. 2021 Jan 22. pii: S0140-6736(21)00151.
    >> Share

  616. PRIESEMANN V, Balling R, Brinkmann MM, Ciesek S, et al
    An action plan for pan-European defence against new SARS-CoV-2 variants.
    Lancet. 2021 Jan 21. pii: S0140-6736(21)00150.
    >> Share

  617. IMPOUMA B, Mboussou F, Kasolo F, Yoti Z, et al
    Preparing for a COVID-19 resurgence in the WHO African region.
    Lancet. 2021 Jan 20. pii: S0140-6736(20)32725.
    >> Share

  618. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Using EM data to understand COVID-19 pathophysiology - Authors' reply.
    Lancet. 2021;397:197-198.
    >> Share

  619. DOLHNIKOFF M, Duarte-Neto AN, Saldiva PHN, Caldini EG, et al
    Using EM data to understand COVID-19 pathophysiology.
    Lancet. 2021;397:196-197.
    >> Share

  620. WEBSTER P
    COVID-19 highlights Canada's care home crisis.
    Lancet. 2021;397:183.
    >> Share

  621. LANE R
    Anne Johnson: Dame of public health epidemiology.
    Lancet. 2021;397:186.
    >> Share

  622. JAFFE S
    New leadership at the US CDC.
    Lancet. 2021;397:182.
    >> Share

  623. THE LANCET
    An opportunity for American renewal.
    Lancet. 2021;397:171.
    >> Share

  624. CAVALERI M, Enzmann H, Straus S, Cooke E, et al
    The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines.
    Lancet. 2021 Jan 13. pii: S0140-6736(21)00085.
    >> Share

  625. BARBARO RP, MacLaren G, Brodie D
    ECMO support for COVID-19: a balancing act - Authors' reply.
    Lancet. 2021;397:95.
    >> Share

  626. ZHANG Y, Ji B, Zhou Z
    ECMO support for COVID-19: a balancing act.
    Lancet. 2021;397:94-95.
    >> Share

  627. KUSIN S, Choo E
    Parenting in the time of COVID-19.
    Lancet. 2021;397:86.
    >> Share

  628. USHER AD
    Health systems neglected by COVID-19 donors.
    Lancet. 2021;397:83.
    >> Share

  629. KNEEBONE R, Schlegel C
    Thinking across disciplinary boundaries in a time of crisis.
    Lancet. 2021;397:89-90.
    >> Share

  630. COUSINS S
    Polio in Afghanistan: a changing landscape.
    Lancet. 2021;397:84-85.
    >> Share

  631. WATTS N, Amann M, Arnell N, Ayeb-Karlsson S, et al
    The 2020 report of The Lancet Countdown on health and climate change: responding to converging crises.
    Lancet. 2021;397:129-170.
    >> Share

  632. CORTINOVIS M, Perico N, Remuzzi G
    Long-term follow-up of recovered patients with COVID-19.
    Lancet. 2021 Jan 8. pii: S0140-6736(21)00039.
    >> Share

  633. HUANG C, Huang L, Wang Y, Li X, et al
    6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.
    Lancet. 2021 Jan 8. pii: S0140-6736(20)32656.
    >> Share

  634. THE LANCET
    Health as a foundation for society.
    Lancet. 2021;397:1.
    >> Share

  635. DEVI S
    2021: a year of humanitarian need.
    Lancet. 2021;397:12-13.
    >> Share

  636. GOSTIN LO, Shalala DE, Hamburg MA, Bloom BR, et al
    A global health action agenda for the Biden administration.
    Lancet. 2021;397:5-8.
    >> Share

  637. KNIPPER M, Bozorgmehr K, Offe J, Orcutt M, et al
    Germany's new global health strategy: leaving migrants behind.
    Lancet. 2021;397:20-21.
    >> Share

  638. ROBERTS DE
    Abolish race correction.
    Lancet. 2021;397:17-18.
    >> Share

  639. ROCHON PA, Stall NM, Gurwitz JH
    Making older women visible.
    Lancet. 2021;397:21.
    >> Share

    December 2020
  640. CLAESON M, Hanson S
    COVID-19 and the Swedish enigma.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32750.
    >> Share

  641. HARMAN S, Herten-Crabb A, Morgan R, Smith J, et al
    COVID-19 vaccines and women's security.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32727.
    >> Share

  642. GOODMAN J, de Prudhoe K, Williams C
    UK COVID-19 public inquiry needed to learn lessons and save lives.
    Lancet. 2020 Dec 22. pii: S0140-6736(20)32726.
    >> Share

  643. SAYAMPANATHAN AA, Heng CS, Pin PH, Pang J, et al
    Infectivity of asymptomatic versus symptomatic COVID-19.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32651.
    >> Share

  644. PRIESEMANN V, Brinkmann MM, Ciesek S, Cuschieri S, et al
    Calling for pan-European commitment for rapid and sustained reduction in SARS-CoV-2 infections.
    Lancet. 2020 Dec 18. pii: S0140-6736(20)32625.
    >> Share

  645. WOODHAMS C, Dacre J, Parnerkar I, Sharma M, et al
    Pay gaps in medicine and the impact of COVID-19 on doctors' careers.
    Lancet. 2020 Dec 15. pii: S0140-6736(20)32671.
    >> Share

  646. KUNG S, Doppen M, Black M, Hills T, et al
    Reduced mortality in New Zealand during the COVID-19 pandemic.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32647.
    >> Share

  647. FITZPATRICK MC, Pandey A, Wells CR, Sah P, et al
    Buyer beware: inflated claims of sensitivity for rapid COVID-19 tests.
    Lancet. 2020 Dec 14. pii: S0140-6736(20)32635.
    >> Share

  648. BRAUN F, Edler C, Puelles VG, Huber TB, et al
    Association of SARS-CoV-2 renal tropism with acute kidney injury - Authors' reply.
    Lancet. 2020;396:1881-1882.
    >> Share

  649. CHOY KW
    Association of SARS-CoV-2 renal tropism with acute kidney injury.
    Lancet. 2020;396:1880-1881.
    >> Share

  650. LANGE B
    Maintaining a gendered perspective in scientific meetings during the COVID-19 pandemic.
    Lancet. 2020;396:1880.
    >> Share

  651. TOPOL EJ
    Is my cough COVID-19?
    Lancet. 2020;396:1874.
    >> Share

  652. SIVA N
    Experts call to include prisons in COVID-19 vaccine plans.
    Lancet. 2020;396:1870.
    >> Share

  653. THE LANCET
    Facing up to long COVID.
    Lancet. 2020;396:1861.
    >> Share

  654. BURGESS RA, Osborne RH, Yongabi KA, Greenhalgh T, et al
    The COVID-19 vaccines rush: participatory community engagement matters more than ever.
    Lancet. 2020 Dec 10. pii: S0140-6736(20)32642.
    >> Share

  655. ARYEETEY E, Engebretsen E, Gornitzka A, Maassen P, et al
    A step backwards in the fight against global vaccine inequities.
    Lancet. 2020 Dec 9. pii: S0140-6736(20)32596.
    >> Share

  656. KNOLL MD, Wonodi C
    Oxford-AstraZeneca COVID-19 vaccine efficacy.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32623.
    >> Share

  657. VOYSEY M, Clemens SAC, Madhi SA, Weckx LY, et al
    Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK.
    Lancet. 2020 Dec 8. pii: S0140-6736(20)32661.
    >> Share

  658. USHER AD
    South Africa and India push for COVID-19 patents ban.
    Lancet. 2020;396:1790-1791.
    >> Share

  659. HORTON R
    Offline: COVID-19-what have we learned so far?
    Lancet. 2020;396:1789.
    >> Share

  660. THE LANCET
    An African plan to control COVID-19 is urgently needed.
    Lancet. 2020;396:1777.
    >> Share

  661. MOLYNEUX DH, Eberhard ML, Cleaveland S, Addey R, et al
    Certifying Guinea worm eradication: current challenges.
    Lancet. 2020;396:1857-1860.
    >> Share

  662. BRIGGS ADM, Fraser C
    Is NHS Test and Trace exacerbating COVID-19 inequalities?
    Lancet. 2020 Dec 4. pii: S0140-6736(20)32593.
    >> Share

  663. THE LANCET
    Climate and COVID-19: converging crises.
    Lancet. 2020 Dec 2. pii: S0140-6736(20)32579.
    >> Share

  664. LAL A, Erondu NA, Heymann DL, Gitahi G, et al
    Fragmented health systems in COVID-19: rectifying the misalignment between global health security and universal health coverage.
    Lancet. 2020 Dec 1. pii: S0140-6736(20)32228.
    >> Share

    November 2020
  665. HERNANDEZ JM
    SARS-CoV-2 risk misclassification explains poor COVID-19 management.
    Lancet. 2020;396:1733-1734.
    >> Share

  666. MENDENHALL E
    The COVID-19 syndemic is not global: context matters.
    Lancet. 2020;396:1731.
    >> Share

  667. FODJE T, Choo E
    Applying for residency in the time of COVID-19.
    Lancet. 2020;396:1718.
    >> Share

  668. COUSINS S
    Afghanistan braced for second wave of COVID-19.
    Lancet. 2020;396:1716-1717.
    >> Share

  669. HORTON R
    Offline: Europe and COVID-19-struggling with tragedy.
    Lancet. 2020;396:1713.
    >> Share

  670. THE LANCET
    Maintaining the HIV response in a world shaped by COVID-19.
    Lancet. 2020;396:1703.
    >> Share

  671. GOGA A, Bekker LG, Van de Perre P, El-Sadr W, et al
    Centring adolescent girls and young women in the HIV and COVID-19 responses.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32552.
    >> Share

  672. BEYRER C, Sullivan P, Adimora AA, Mayer K, et al
    HIV in the USA: priorities for the new administration.
    Lancet. 2020 Nov 27. pii: S0140-6736(20)32524.
    >> Share

  673. HILLS T, Kearns N, Kearns C, Beasley R, et al
    Influenza control during the COVID-19 pandemic.
    Lancet. 2020;396:1633-1634.
    >> Share

  674. THE LANCET
    COVID-19 vaccines: no time for complacency.
    Lancet. 2020;396:1607.
    >> Share

  675. GRIFFITHS C, Mitchell M, Burnand A
    More support needed for UK charity-funded medical research.
    Lancet. 2020;396:1616-1618.
    >> Share

  676. AL-MANDHARI AS, Brennan RJ, Abubakar A, Hajjeh R, et al
    Tackling COVID-19 in the Eastern Mediterranean Region.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32349.
    >> Share

  677. MATHUR R, Bear L, Khunti K, Eggo RM, et al
    Urgent actions and policies needed to address COVID-19 among UK ethnic minorities.
    Lancet. 2020 Nov 19. pii: S0140-6736(20)32465.
    >> Share

  678. RAMASAMY MN, Minassian AM, Ewer KJ, Flaxman AL, et al
    Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32466.
    >> Share

  679. ANDREW MK, McElhaney JE
    Age and frailty in COVID-19 vaccine development.
    Lancet. 2020 Nov 18. pii: S0140-6736(20)32481.
    >> Share

  680. STEFANICK ML, Schiebinger L
    Analysing how sex and gender interact.
    Lancet. 2020;396:1553-1554.
    >> Share

  681. CHANDAN JS
    Improving global surveillance of gender-based violence.
    Lancet. 2020;396:1562.
    >> Share

  682. AL KNAWY B, Adil M, Crooks G, Rhee K, et al
    The Riyadh Declaration: the role of digital health in fighting pandemics.
    Lancet. 2020;396:1537-1539.
    >> Share

  683. SHAW A, Flott K, Fontana G, Durkin M, et al
    No patient safety without health worker safety.
    Lancet. 2020;396:1541-1543.
    >> Share

  684. MOLLICA RF, Fernando D
    When racial trauma is a chief complaint among health-care staff.
    Lancet. 2020;396:e84.
    >> Share

  685. CASTRO A
    Maternal and child mortality worsens in Latin America and the Caribbean.
    Lancet. 2020;396:e85.
    >> Share

  686. PONIKOWSKI P, Kirwan BA, Anker SD, McDonagh T, et al
    Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial.
    Lancet. 2020 Nov 12. pii: S0140-6736(20)32339.
    >> Share

  687. FORE HH, Ghebreyesus TA, Watkins K, Greenslade L, et al
    Leveraging the COVID-19 response to end preventable child deaths from pneumonia.
    Lancet. 2020 Nov 11. pii: S0140-6736(20)32348.
    >> Share

  688. ZIMERMAN A, Lopes RD, D'Avila A, Rohde LE, et al
    COVID-19 in Brazil: the headlines should be about science.
    Lancet. 2020 Nov 10. pii: S0140-6736(20)32375.
    >> Share

  689. GURDASANI D, Bear L, Bogaert D, Burgess RA, et al
    The UK needs a sustainable strategy for COVID-19.
    Lancet. 2020 Nov 9. pii: S0140-6736(20)32350.
    >> Share

  690. KRIEGER N, Testa C, Hanage WP, Chen JT, et al
    US racial and ethnic data for COVID-19 cases: still missing in action.
    Lancet. 2020;396:e81.
    >> Share

  691. COVIDSURG COLLABORATIVE
    Surgery during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:e79.
    >> Share

  692. VUTHALURU S, Koliyadan SV, Kanniwadi SS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e78.
    >> Share

  693. MEECHAM L, Shakarchi JA, Rahman HP, Nyamekye IK, et al
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e77.
    >> Share

  694. ALDERMAN J
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e76.
    >> Share

  695. RODRIGUES J, Chan JK, Issa F
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e75.
    >> Share

  696. SHANTHANNA H, Uppal V
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e74.
    >> Share

  697. HAMID HKS
    Surgery during the COVID-19 pandemic.
    Lancet. 2020;396:e73.
    >> Share

  698. HUNG IF, Yuen KY
    Early triple antiviral therapy for COVID-19 - Authors' reply.
    Lancet. 2020;396:1488.
    >> Share

  699. LEE N, Ison M, Dunning J
    Early triple antiviral therapy for COVID-19.
    Lancet. 2020;396:1487-1488.
    >> Share

  700. VOYSEY M, Pollard AJ
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 - Authors' reply.
    Lancet. 2020;396:1486-1487.
    >> Share

  701. LODGE A
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1486.
    >> Share

  702. CHAUHAN A, Agarwal A, Jaiswal N, Singh M, et al
    ChAdOx1 nCoV-19 vaccine for SARS-CoV-2.
    Lancet. 2020;396:1485-1486.
    >> Share

  703. HOFFMANN C, Wolf E
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  704. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    SARS-CoV-2 seroprevalence in Spain - Authors' reply.
    Lancet. 2020;396:1484-1485.
    >> Share

  705. GEORGE TP
    SARS-CoV-2 seroprevalence in Spain.
    Lancet. 2020;396:1484.
    >> Share

  706. HORTON R
    Offline: Managing the COVID-19 vaccine infodemic.
    Lancet. 2020;396:1474.
    >> Share

  707. DZAU VJ, Balatbat C
    Strategy, coordinated implementation, and sustainable financing needed for COVID-19 innovations.
    Lancet. 2020;396:1469-1471.
    >> Share

  708. THE LANCET
    COVID-19 in Latin America: a humanitarian crisis.
    Lancet. 2020;396:1463.
    >> Share

  709. BHADORIA AS, Gawande K, Sharma R, Mohapatra A, et al
    Institutional versus home isolation to curb the COVID-19 outbreak.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32161.
    >> Share

  710. WILDER-SMITH A, Cook AR, Dickens BL
    Institutional versus home isolation to curb the COVID-19 outbreak - Authors' reply.
    Lancet. 2020 Nov 6. pii: S0140-6736(20)32171.
    >> Share

  711. SMITH MJ, Ujewe S, Katz R, Upshur REG, et al
    Emergency use authorisation for COVID-19 vaccines: lessons from Ebola.
    Lancet. 2020 Nov 5. pii: S0140-6736(20)32337.
    >> Share

  712. ANDERSON RM, Vegvari C, Truscott J, Collyer BS, et al
    Challenges in creating herd immunity to SARS-CoV-2 infection by mass vaccination.
    Lancet. 2020 Nov 4. pii: S0140-6736(20)32318.
    >> Share

  713. HOPKINS C, Smith B
    Widespread smell testing for COVID-19 has limited application.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32317.
    >> Share

  714. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Widespread smell testing for COVID-19 has limited application - Authors' reply.
    Lancet. 2020 Nov 3. pii: S0140-6736(20)32316.
    >> Share

    October 2020
  715. OKELL LC, Verity R, Katzourakis A, Volz EM, et al
    Host or pathogen-related factors in COVID-19 severity? - Authors' reply.
    Lancet. 2020;396:1397.
    >> Share

  716. GORTAZAR C, Del-Rio FJR, Dominguez L, de la Fuente J, et al
    Host or pathogen-related factors in COVID-19 severity?
    Lancet. 2020;396:1396-1397.
    >> Share

  717. QU Z, Oedingen C, Bartling T, Schrem H, et al
    Organ procurement and transplantation in Germany during the COVID-19 pandemic.
    Lancet. 2020;396:1395.
    >> Share

  718. REDDY S, Dumbill R, Akhtar MZ, Udupa V, et al
    Transplant programmes in areas with high SARS-CoV-2 transmission.
    Lancet. 2020;396:1395-1396.
    >> Share

  719. TREIBEL TA, Manisty C, Andiapen M, Pade C, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1394-1395.
    >> Share

  720. CHOW A, Htun HL, Kyaw WM, Lee LT, et al
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393-1394.
    >> Share

  721. FENNELLY K, Whalen CC
    Asymptomatic health-care worker screening during the COVID-19 pandemic.
    Lancet. 2020;396:1393.
    >> Share

  722. HOLT E
    Slovakia to test all adults for SARS-CoV-2.
    Lancet. 2020;396:1386-1387.
    >> Share

  723. HORTON R
    Offline: COVID-19-a crisis of power.
    Lancet. 2020;396:1383.
    >> Share

  724. FREUDENTHAL R, Horowitz M, Jadhav S, Moncrieff J, et al
    Lack of safeguards in response to restrictive public health measures.
    Lancet. 2020;396:e70.
    >> Share

  725. HASSAN-SMITH Z, Hanif W, Khunti K
    Who should be prioritised for COVID-19 vaccines?
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32224.
    >> Share

  726. KENYON C
    Syndemic responses to COVID-19 should include an ecological dimension.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32219.
    >> Share

  727. KRAUSE PR, Fleming TR, Ellenberg SS, Henao-Restrepo AM, et al
    Maintaining confidentiality of emerging results in COVID-19 vaccine trials is essential.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32259.
    >> Share

  728. BINGHAM K
    The UK Government's Vaccine Taskforce: strategy for protecting the UK and the world.
    Lancet. 2020 Oct 27. pii: S0140-6736(20)32175.
    >> Share

  729. FERIGATO S, Fernandez M, Amorim M, Ambrogi I, et al
    The Brazilian Government's mistakes in responding to the COVID-19 pandemic.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32164.
    >> Share

  730. STEWART R, El-Harakeh A, Cherian SA
    Evidence synthesis communities in low-income and middle-income countries and the COVID-19 response.
    Lancet. 2020 Oct 20. pii: S0140-6736(20)32141.
    >> Share

  731. PAES-SOUSA R, Millett C, Rocha R, Barreto ML, et al
    Science misuse and polarised political narratives in the COVID-19 response.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32168.
    >> Share

  732. BUCHBINDER SP, McElrath MJ, Dieffenbach C, Corey L, et al
    Use of adenovirus type-5 vectored vaccines: a cautionary tale.
    Lancet. 2020 Oct 19. pii: S0140-6736(20)32156.
    >> Share

  733. THE LANCET
    Global health: time for radical change?
    Lancet. 2020;396:1129.
    >> Share

  734. PETO J, Hunter DJ, Riboli E, Griffin JL, et al
    Unnecessary obstacles to COVID-19 mass testing.
    Lancet. 2020 Oct 16. pii: S0140-6736(20)32170.
    >> Share

  735. USUELLI M
    The Lombardy region of Italy launches the first investigative COVID-19 commission.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32154.
    >> Share

  736. ALWAN NA, Burgess RA, Ashworth S, Beale R, et al
    Scientific consensus on the COVID-19 pandemic: we need to act now.
    Lancet. 2020 Oct 15. pii: S0140-6736(20)32153.
    >> Share

  737. POLAND GA, Ovsyannikova IG, Kennedy RB
    SARS-CoV-2 immunity: review and applications to phase 3 vaccine candidates.
    Lancet. 2020 Oct 13. pii: S0140-6736(20)32137.
    >> Share

  738. HONIGSBAUM M, Krishnan L
    Taking pandemic sequelae seriously: from the Russian influenza to COVID-19 long-haulers.
    Lancet. 2020 Oct 12. pii: S0140-6736(20)32134.
    >> Share

  739. BLUKACZ A, Cabieses B
    COVID-19: leaving no one behind in Latin America.
    Lancet. 2020;396:1070.
    >> Share

  740. CHARLIER P, Varison L
    Is COVID-19 being used as a weapon against Indigenous Peoples in Brazil?
    Lancet. 2020;396:1069-1070.
    >> Share

  741. KUDERER NM, Wulff-Burchfield E, Rubinstein SM, Grivas P, et al
    Cancer and COVID-19 - Authors' reply.
    Lancet. 2020;396:1067-1068.
    >> Share

  742. MALEK AE, Raad II, Jabbour E
    Cancer and COVID-19.
    Lancet. 2020;396:1066-1067.
    >> Share

  743. MORIS D, Tsilimigras DI, Schizas D
    Cancer and COVID-19.
    Lancet. 2020;396:1066.
    >> Share

  744. GROSS R, Conzelmann C, Muller JA, Reister F, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:1065-1066.
    >> Share

  745. CUMMINGS MJ, O'Donnell MR
    Study of critically ill patients with COVID-19 in New York City - Authors' reply.
    Lancet. 2020;396:1064.
    >> Share

  746. SHENKER NS, Wesolowska A, van Goudoever JB, Nangia S, et al
    Undermining breastfeeding will not alleviate the COVID-19 pandemic.
    Lancet. 2020;396:1064-1065.
    >> Share

  747. PIOVANI D, Bonovas S
    Study of critically ill patients with COVID-19 in New York City.
    Lancet. 2020;396:1064.
    >> Share

  748. CALLENDER B, Obuobi S, Czerwiec MK, Williams I, et al
    COVID-19, comics, and the visual culture of contagion.
    Lancet. 2020;396:1061-1063.
    >> Share

  749. COUSINS S
    2.5 million more child marriages due to COVID-19 pandemic.
    Lancet. 2020;396:1059.
    >> Share

  750. THE LANCET
    Mental health: time to invest in quality.
    Lancet. 2020;396:1045.
    >> Share

  751. FRUMKIN H, Myers SS
    Planetary health and the 2020 US election.
    Lancet. 2020;396:1048-1050.
    >> Share

  752. ALLOTEY P, Denton F
    Challenges and priorities for delivering on the Beijing Declaration and Platform for Action 25 years on.
    Lancet. 2020;396:1053-1055.
    >> Share

  753. CARLET J, Payen D, Opal SM
    Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
    Lancet. 2020 Oct 9. pii: S0140-6736(20)32132.
    >> Share

  754. VAN TULLEKEN C, Wright C, Brown A, McCoy D, et al
    Marketing of breastmilk substitutes during the COVID-19 pandemic.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32119.
    >> Share

  755. BEDFORD J, Enria D, Giesecke J, Heymann DL, et al
    Living with the COVID-19 pandemic: act now with the tools we have.
    Lancet. 2020 Oct 8. pii: S0140-6736(20)32117.
    >> Share


  756. Lopinavir-ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32013.
    >> Share

  757. DITTMAYER C, Meinhardt J, Radbruch H, Radke J, et al
    Why misinterpretation of electron micrographs in SARS-CoV-2-infected tissue goes viral.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32079.
    >> Share

  758. BOZORGMEHR K
    Power of and power over COVID-19 response guidelines.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32081.
    >> Share

  759. CAO B, Hayden FG
    Antiviral monotherapy for hospitalised patients with COVID-19 is not enough.
    Lancet. 2020 Oct 5. pii: S0140-6736(20)32078.
    >> Share

  760. DENING KH, Lloyd-Williams M
    Minimising long-term effect of COVID-19 in dementia care.
    Lancet. 2020;396:957-958.
    >> Share

  761. WANG Y, Gu X, Xu J, Cao B, et al
    Remdesivir and COVID-19 - Authors' reply.
    Lancet. 2020;396:954.
    >> Share

  762. WANG LY, Cui JJ, Ouyang QY, Zhan Y, et al
    Remdesivir and COVID-19.
    Lancet. 2020;396:953-954.
    >> Share

  763. EDWARDS JK, Cole SR, Adimora AA
    Remdesivir and COVID-19.
    Lancet. 2020;396:953.
    >> Share

  764. GLAUS MJ, Von Ruden S
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    >> Share

  765. DENNIS A
    Remdesivir and COVID-19.
    Lancet. 2020;396:952.
    >> Share

  766. MCMAHON JH, Hoy JF, Kamarulzaman A, Bekker LG, et al
    Leveraging the advances in HIV for COVID-19.
    Lancet. 2020;396:943-944.
    >> Share

  767. THE LANCET
    Building a resilient NHS, for COVID-19 and beyond.
    Lancet. 2020;396:935.
    >> Share

    September 2020
  768. CAUCHEMEZ S, Kiem CT, Paireau J, Rolland P, et al
    Lockdown impact on COVID-19 epidemics in regions across metropolitan France.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32034.
    >> Share

  769. STRATHDEE SA, Davies SC, Marcelin JR
    Confronting antimicrobial resistance beyond the COVID-19 pandemic and the 2020 US election.
    Lancet. 2020 Sep 29. pii: S0140-6736(20)32063.
    >> Share

  770. LASRY A, Horth R
    Models for mortality require tailoring in the context of the COVID-19 pandemic.
    Lancet. 2020;396:883.
    >> Share

  771. BANERJEE A, Pasea L, Denaxas S, Williams B, et al
    Models for mortality require tailoring in the context of the COVID-19 pandemic - Authors' reply.
    Lancet. 2020;396:883-884.
    >> Share

  772. HAGAY Z
    Israeli aid to the West Bank and the Gaza Strip during the COVID-19 pandemic.
    Lancet. 2020;396:882.
    >> Share

  773. HORTON R
    Offline: COVID-19 is not a pandemic.
    Lancet. 2020;396:874.
    >> Share

  774. THE LANCET
    COVID-19 in India: the dangers of false optimism.
    Lancet. 2020;396:867.
    >> Share

  775. JAFFE S
    Media reports reveal political interference at the US CDC.
    Lancet. 2020;396:875.
    >> Share

  776. BALL P
    David Hare's fiery account of COVID-19.
    Lancet. 2020;396:878-879.
    >> Share

  777. FLOWER B, Atchison C
    SARS-CoV-2 antibody seroprevalence in patients receiving dialysis in the USA.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32006.
    >> Share

  778. BARBARO RP, MacLaren G, Boonstra PS, Iwashyna TJ, et al
    Extracorporeal membrane oxygenation support in COVID-19: an international cohort study of the Extracorporeal Life Support Organization registry.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32008.
    >> Share

  779. ANAND S, Montez-Rath M, Han J, Bozeman J, et al
    Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
    Lancet. 2020 Sep 25. pii: S0140-6736(20)32009.
    >> Share

  780. HAN E, Tan MMJ, Turk E, Sridhar D, et al
    Lessons learnt from easing COVID-19 restrictions: an analysis of countries and regions in Asia Pacific and Europe.
    Lancet. 2020 Sep 24. pii: S0140-6736(20)32007.
    >> Share

  781. LOGUNOV DY, Dolzhikova IV, Tukhvatullin AI, Shcheblyakov DV, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed - Authors' reply.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31970.
    >> Share

  782. PEIRIS M, Leung GM
    What can we expect from first-generation COVID-19 vaccines?
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31976.
    >> Share

  783. BUCCI E, Andreev K, Bjorkman A, Calogero RA, et al
    Safety and efficacy of the Russian COVID-19 vaccine: more information needed.
    Lancet. 2020 Sep 21. pii: S0140-6736(20)31960.
    >> Share

  784. MARINHO PM, Nascimento H, Marcos AAA, Romano AC, et al
    Seeking clarity on retinal findings in patients with COVID-19 - Authors' reply.
    Lancet. 2020;396:e40.
    >> Share

  785. DUH EJ
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e39.
    >> Share

  786. COLLISON FT, Carroll J
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e38.
    >> Share

  787. BRANDAO-DE-RESENDE C, Diniz-Filho A, Vasconcelos-Santos DV
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e37.
    >> Share

  788. VENKATESH P
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e36.
    >> Share

  789. OUYANG P, Zhang X, Peng Y, Jiang B, et al
    Seeking clarity on retinal findings in patients with COVID-19.
    Lancet. 2020;396:e35.
    >> Share

  790. PONTES MRN, Lima JP
    Brazil's COVID-19 response.
    Lancet. 2020;396:e34.
    >> Share

  791. RIZZO LV, Wolosker N
    Brazil's COVID-19 response.
    Lancet. 2020;396:e33.
    >> Share

  792. VALENTE DS, Zanella RK
    Brazil's COVID-19 response.
    Lancet. 2020;396:e32.
    >> Share

  793. DA SILVA BASTOS MH
    Brazil's COVID-19 response.
    Lancet. 2020;396:e31.
    >> Share

  794. DE ANDREAZZI CS, Brandao ML, Bueno MG, Winck GR, et al
    Brazil's COVID-19 response.
    Lancet. 2020;396:e30.
    >> Share

  795. AGREN D
    Understanding Mexican health worker COVID-19 deaths.
    Lancet. 2020;396:807.
    >> Share

  796. THE LANCET
    COVID-19: a stress test for trust in science.
    Lancet. 2020;396:799.
    >> Share

  797. KLEINERT S, Horton R
    Preprints with The Lancet are here to stay.
    Lancet. 2020;396:805.
    >> Share

  798. JONES D, Helmreich S
    A history of herd immunity.
    Lancet. 2020;396:810-811.
    >> Share

  799. GALEA S, Ettman CK, Abdalla SM
    Access to health care and the 2020 US election.
    Lancet. 2020;396:803-805.
    >> Share


  800. Lancet COVID-19 Commission Statement on the occasion of the 75th session of the UN General Assembly.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31927.
    >> Share

  801. SLIWA K, Yacoub M
    Catalysing the response to NCDI Poverty at a time of COVID-19.
    Lancet. 2020 Sep 14. pii: S0140-6736(20)31911.
    >> Share

  802. THE LANCET
    Global collaboration for health: rhetoric versus reality.
    Lancet. 2020;396:735.
    >> Share

  803. PHELAN AL, Eccleston-Turner M, Rourke M, Maleche A, et al
    Legal agreements: barriers and enablers to global equitable COVID-19 vaccine access.
    Lancet. 2020 Sep 7. pii: S0140-6736(20)31873.
    >> Share

  804. DEVI S
    COVID-19 exacerbates violence against health workers.
    Lancet. 2020;396:658.
    >> Share

  805. CHATTERJEE P
    Is India missing COVID-19 deaths?
    Lancet. 2020;396:657.
    >> Share

  806. THE LANCET
    COVID-19: a new lens for non-communicable diseases.
    Lancet. 2020;396:649.
    >> Share

  807. OLDENBURG CE, Doan T
    Azithromycin for severe COVID-19.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31863.
    >> Share

  808. FURTADO RHM, Berwanger O, Fonseca HA, Correa TD, et al
    Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial.
    Lancet. 2020 Sep 4. pii: S0140-6736(20)31862.
    >> Share

  809. LOGUNOV DY, Dolzhikova IV, Zubkova OV, Tukhvatullin AI, et al
    Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31866.
    >> Share

  810. BAR-ZEEV N, Inglesby T
    COVID-19 vaccines: early success and remaining challenges.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31867.
    >> Share

  811. ALICANDRO G, Remuzzi G, La Vecchia C
    Italy's first wave of the COVID-19 pandemic has ended: no excess mortality in May, 2020.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31865.
    >> Share

  812. KOCA F
    Promotion of scientific research on COVID-19 in Turkey.
    Lancet. 2020 Sep 3. pii: S0140-6736(20)31864.
    >> Share

    August 2020
  813. MCLENNAN AK, Hansen AKK, Ulijaszek SJ
    Health and medicine cannot solve COVID-19.
    Lancet. 2020;396:599-600.
    >> Share

  814. COUSINS S
    Bangladesh's COVID-19 testing criticised.
    Lancet. 2020;396:591.
    >> Share

  815. THE LANCET
    Research and higher education in the time of COVID-19.
    Lancet. 2020;396:583.
    >> Share

  816. FISHER DA, Carson G
    Back to basics: the outbreak response pillars.
    Lancet. 2020;396:598.
    >> Share

  817. ROSADAS C, Randell P, Khan M, McClure MO, et al
    Testing for responses to the wrong SARS-CoV-2 antigen?
    Lancet. 2020 Aug 28. pii: S0140-6736(20)31830.
    >> Share

  818. KRAUSE P, Fleming TR, Longini I, Henao-Restrepo AM, et al
    COVID-19 vaccine trials should seek worthwhile efficacy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31821.
    >> Share

  819. DASHRAATH P, Nielsen-Saines K, Madhi SA, Baud D, et al
    COVID-19 vaccines and neglected pregnancy.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31822.
    >> Share

  820. ALWAN NA
    Surveillance is underestimating the burden of the COVID-19 pandemic.
    Lancet. 2020 Aug 27. pii: S0140-6736(20)31823.
    >> Share

  821. VAN DORN A
    COVID-19 and readjusting clinical trials.
    Lancet. 2020;396:523-524.
    >> Share

  822. MAUVAIS-JARVIS F, Bairey Merz N, Barnes PJ, Brinton RD, et al
    Sex and gender: modifiers of health, disease, and medicine.
    Lancet. 2020;396:565-582.
    >> Share

  823. THE LANCET
    Trump versus Biden: a fight for the health of a nation.
    Lancet. 2020;396:513.
    >> Share

  824. VERKUIL LD, Liu GT, Brahma VL, Avery RA, et al
    Pseudotumor cerebri syndrome associated with MIS-C: a case report.
    Lancet. 2020;396:532.
    >> Share

  825. YOUNG BE, Fong SW, Chan YH, Mak TM, et al
    Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
    Lancet. 2020 Aug 18. pii: S0140-6736(20)31757.
    >> Share

  826. BUSE K, Nilo A, Kim J, Heywood M, et al
    COVID-19 combination prevention requires attention to structural drivers.
    Lancet. 2020;396:466.
    >> Share

  827. MANARA AR, Mumford L, Callaghan CJ, Ravanan R, et al
    Donation and transplantation activity in the UK during the COVID-19 lockdown.
    Lancet. 2020;396:465-466.
    >> Share

  828. BAYRAM H, Kokturk N, Elbek O, Kilinc O, et al
    Interference in scientific research on COVID-19 in Turkey.
    Lancet. 2020;396:463-464.
    >> Share

  829. WATT RG
    COVID-19 is an opportunity for reform in dentistry.
    Lancet. 2020;396:462.
    >> Share

  830. GERTNER E
    COVID-19 trial co-enrolment and subsequent enrolment.
    Lancet. 2020;396:461-462.
    >> Share

  831. MAKONI M
    COVID-19 worsens Zimbabwe's health crisis.
    Lancet. 2020;396:457.
    >> Share

  832. PEETERS A, Mullins G, Becker D, Orellana L, et al
    COVID-19's impact on Australia's health research workforce.
    Lancet. 2020;396:461.
    >> Share

  833. THE LANCET
    Humanitarian crises in a global pandemic.
    Lancet. 2020;396:447.
    >> Share

  834. BRAUN F, Lutgehetmann M, Pfefferle S, Wong MN, et al
    SARS-CoV-2 renal tropism associates with acute kidney injury.
    Lancet. 2020 Aug 14. pii: S0140-6736(20)31759.
    >> Share

  835. JAMIOLKOWSKI D, Muhleisen B, Muller S, Navarini AA, et al
    SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report.
    Lancet. 2020 Aug 13. pii: S0140-6736(20)31754.
    >> Share

  836. BHOPAL SS, Bhopal R
    Sex differential in COVID-19 mortality varies markedly by age.
    Lancet. 2020 Aug 13. pii: S0140-6736(20)31748.
    >> Share

  837. AIYEGBUSI OL, Calvert MJ
    Patient-reported outcomes: central to the management of COVID-19.
    Lancet. 2020 Aug 10. pii: S0140-6736(20)31724.
    >> Share

  838. GIESECKE J
    COVID-19-a very visible pandemic - Author's reply.
    Lancet. 2020;396:e20.
    >> Share

  839. KEIL EJ
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e19.
    >> Share

  840. EWING A
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e18.
    >> Share

  841. DURRHEIM DN, Baker MG
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e17.
    >> Share

  842. LINDAHL JF, Olsen B, Lundkvist A
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e16.
    >> Share

  843. KING C, Einhorn L, Brusselaers N, Carlsson M, et al
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e15.
    >> Share

  844. RAMACHANDRAN R
    COVID-19-a very visible pandemic.
    Lancet. 2020;396:e13-e14.
    >> Share

  845. DEVI S
    Egyptian health workers arrested after COVID-19 comments.
    Lancet. 2020;396:369.
    >> Share

  846. CROVETTO F, Crispi F, Llurba E, Figueras F, et al
    Seroprevalence and presentation of SARS-CoV-2 in pregnancy.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31714.
    >> Share

  847. FANCOURT D, Steptoe A, Wright L
    The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31690.
    >> Share

  848. GARCIA-BASTEIRO A, Alvarez-Dardet C, Arenas A, Bengoa R, et al
    The need for an independent evaluation of the COVID-19 response in Spain.
    Lancet. 2020 Aug 6. pii: S0140-6736(20)31713.
    >> Share

  849. ANDERSON RM, Hollingsworth TD, Baggaley RF, Maddren R, et al
    COVID-19 spread in the UK: the end of the beginning?
    Lancet. 2020 Aug 3. pii: S0140-6736(20)31689.
    >> Share

  850. COUSINS S
    COVID-19 has "devastating" effect on women and girls.
    Lancet. 2020;396:301-302.
    >> Share

  851. THE LANCET
    The truth is out there, somewhere.
    Lancet. 2020;396:291.
    >> Share

  852. GOSTIN LO, Koh HH, Williams M, Hamburg MA, et al
    US withdrawal from WHO is unlawful and threatens global and US health and security.
    Lancet. 2020;396:293-295.
    >> Share

    July 2020
  853. BARBERIA LG, Gomez EJ
    Political and institutional perils of Brazil's COVID-19 crisis.
    Lancet. 2020 Jul 30. pii: S0140-6736(20)31681.
    >> Share

  854. HEADEY D, Heidkamp R, Osendarp S, Ruel M, et al
    Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality.
    Lancet. 2020 Jul 27. pii: S0140-6736(20)31647.
    >> Share

  855. FORE HH, Dongyu Q, Beasley DM, Ghebreyesus TA, et al
    Child malnutrition and COVID-19: the time to act is now.
    Lancet. 2020 Jul 27. pii: S0140-6736(20)31648.
    >> Share

  856. KARIM SA
    COVID-19 vaccine affordability and accessibility.
    Lancet. 2020;396:238.
    >> Share

  857. EADES S, Eades F, McCaullay D, Nelson L, et al
    Australia's First Nations' response to the COVID-19 pandemic.
    Lancet. 2020;396:237-238.
    >> Share

  858. DANIELS JP
    COVID-19 cases surge in Colombia.
    Lancet. 2020;396:227.
    >> Share

  859. HORTON R
    Offline: Preparing for a vaccine against COVID-19.
    Lancet. 2020;396:226.
    >> Share

  860. LANCET T
    COVID-19 and China: lessons and the way forward.
    Lancet. 2020;396:213.
    >> Share

  861. PHUMAPHI J, Mason E, Alipui NK, Cisnero JR, et al
    A crisis of accountability for women's, children's, and adolescents' health.
    Lancet. 2020;396:222-224.
    >> Share

  862. RUSHTON CH, Doerries B, Greene J, Geller G, et al
    Dramatic interventions in the tragedy of the COVID-19 pandemic.
    Lancet. 2020 Jul 23. pii: S0140-6736(20)31641.
    >> Share

  863. BAR-ZEEV N, Moss WJ
    Encouraging results from phase 1/2 COVID-19 vaccine trials.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31611.
    >> Share

  864. ZHU FC, Guan XH, Li YH, Huang JY, et al
    Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31605.
    >> Share

  865. FOLEGATTI PM, Ewer KJ, Aley PK, Angus B, et al
    Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial.
    Lancet. 2020 Jul 20. pii: S0140-6736(20)31604.
    >> Share

  866. HORTON R
    Offline: COVID-19 and the dangers of Sinophobia.
    Lancet. 2020;396:154.
    >> Share

  867. RUTTER H, Horton R, Marteau TM
    The Lancet-Chatham House Commission on improving population health post COVID-19.
    Lancet. 2020;396:152-153.
    >> Share

  868. NEPOMNYASHCHIY L, Dahn B, Saykpah R, Raghavan M, et al
    COVID-19: Africa needs unprecedented attention to strengthen community health systems.
    Lancet. 2020;396:150-152.
    >> Share

  869. IWAI Y, Khan ZH, DasGupta S
    Abolition medicine.
    Lancet. 2020;396:158-159.
    >> Share

  870. USHER AD
    New funds proposed to prevent pandemics.
    Lancet. 2020;396:155.
    >> Share

  871. THE LANCET
    No more normal.
    Lancet. 2020;396:143.
    >> Share

  872. ROLLSTON R, Wilkinson E, Abouelazm R, Mladenov P, et al
    Comprehensive sexuality education to address gender-based violence.
    Lancet. 2020;396:148-150.
    >> Share

  873. BRADLEY BT, Maioli H, Johnston R, Chaudhry I, et al
    Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series.
    Lancet. 2020 Jul 16. pii: S0140-6736(20)31305.
    >> Share

  874. NORTON A, Mphahlele J, Yazdanpanah Y, Piot P, et al
    Strengthening the global effort on COVID-19 research.
    Lancet. 2020 Jul 16. pii: S0140-6736(20)31598.
    >> Share

  875. ATLANI-DUAULT L, Chauvin F, Yazdanpanah Y, Lina B, et al
    France's COVID-19 response: balancing conflicting public health traditions.
    Lancet. 2020 Jul 16. pii: S0140-6736(20)31599.
    >> Share

  876. FISHER D, Teo YY, Nabarro D
    Assessing national performance in response to COVID-19.
    Lancet. 2020 Jul 15. pii: S0140-6736(20)31601.
    >> Share

  877. MAFHAM MM, Spata E, Goldacre R, Gair D, et al
    COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England.
    Lancet. 2020 Jul 14. pii: S0140-6736(20)31356.
    >> Share

  878. THE LANCET
    COVID-19: the worst may be yet to come.
    Lancet. 2020;396:71.
    >> Share

  879. GILL D, Whitehead C, Wondimagegn D
    Challenges to medical education at a time of physical distancing.
    Lancet. 2020;396:77-79.
    >> Share

  880. CAREL H, Ratcliffe M, Froese T
    Reflecting on experiences of social distancing.
    Lancet. 2020;396:87-88.
    >> Share

  881. ALJAYYOUSSI G
    The harms of police frisking in times of a pandemic.
    Lancet. 2020;396:91.
    >> Share

  882. LOTTA G, Wenham C, Nunes J, Pimenta DN, et al
    Community health workers reveal COVID-19 disaster in Brazil.
    Lancet. 2020 Jul 10. pii: S0140-6736(20)31521.
    >> Share

  883. SHAIGANY S, Gnirke M, Guttmann A, Chong H, et al
    An adult with Kawasaki-like multisystem inflammatory syndrome associated with COVID-19.
    Lancet. 2020 Jul 10. pii: S0140-6736(20)31526.
    >> Share

  884. KIRSCHENBAUM D, Imbach LL, Ulrich S, Rushing EJ, et al
    Inflammatory olfactory neuropathy in two patients with COVID-19.
    Lancet. 2020 Jul 10. pii: S0140-6736(20)31525.
    >> Share

  885. SACHS JD, Horton R, Bagenal J, Amor YB, et al
    The Lancet COVID-19 Commission.
    Lancet. 2020 Jul 9. pii: S0140-6736(20)31494.
    >> Share

  886. FUNCK-BRENTANO C, Nguyen LS, Salem JE
    Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19.
    Lancet. 2020 Jul 9. pii: S0140-6736(20)31528.
    >> Share

  887. HOULIHAN CF, Vora N, Byrne T, Lewer D, et al
    Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.
    Lancet. 2020 Jul 9. pii: S0140-6736(20)31484.
    >> Share

  888. WANG HH, Lau E, Horton R
    The Wakley-Wu Lien Teh Prize Essay 2020: Chinese health workers' experiences during the COVID-19 pandemic.
    Lancet. 2020;396:13.
    >> Share

  889. ECKERLE I, Meyer B
    SARS-CoV-2 seroprevalence in COVID-19 hotspots.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31482.
    >> Share

  890. POLLAN M, Perez-Gomez B, Pastor-Barriuso R, Oteo J, et al
    Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31483.
    >> Share

  891. AL SAIDI AMO, Nur FA, Al-Mandhari AS, El Rabbat M, et al
    Decisive leadership is a necessity in the COVID-19 response.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31493.
    >> Share

  892. KAVANAGH MM, Katz IT, Holmes CB
    Reckoning with mortality: global health, HIV, and the politics of data.
    Lancet. 2020 Jul 3. pii: S0140-6736(20)31046.
    >> Share

  893. NAZARETH J, Minhas JS, Jenkins DR, Sahota A, et al
    Early lessons from a second COVID-19 lockdown in Leicester, UK.
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31490.
    >> Share


  894. After COVID-19, a future for the world's children?
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31481.
    >> Share

  895. KING A, Andrus JK, Figueroa JP
    Financial crisis at PAHO in the time of COVID-19: a call for action.
    Lancet. 2020 Jul 2. pii: S0140-6736(20)31489.
    >> Share

    June 2020
  896. GNECCHI M, Moretti F, Bassi EM, Leonardi S, et al
    Myocarditis in a 16-year-old boy positive for SARS-CoV-2.
    Lancet. 2020;395:e116.
    >> Share

  897. DEVI S
    Access to health care under threat in Afghanistan.
    Lancet. 2020;395:1962.
    >> Share

  898. BANG A
    Faced with today's crisis, what would Gandhi do?
    Lancet. 2020;395:e114-e115.
    >> Share

  899. DEVAKUMAR D, Selvarajah S, Shannon G, Muraya K, et al
    Racism, the public health crisis we can no longer ignore.
    Lancet. 2020;395:e112-e113.
    >> Share

  900. THE LANCET
    Generation coronavirus?
    Lancet. 2020;395:1949.
    >> Share

  901. MARCHALIK D, Petrov D
    Seeing COVID-19 through Jose Saramago's Blindness.
    Lancet. 2020;395:1899.
    >> Share

  902. DEVI S
    COVID-19 resurgence in Iran.
    Lancet. 2020;395:1896.
    >> Share

  903. BAKER P, White A, Morgan R
    Men's health: COVID-19 pandemic highlights need for overdue policy action.
    Lancet. 2020;395:1886-1888.
    >> Share

  904. THE LANCET
    Global governance for COVID-19 vaccines.
    Lancet. 2020;395:1883.
    >> Share

  905. KING T, Hewitt B, Crammond B, Sutherland G, et al
    Reordering gender systems: can COVID-19 lead to improved gender equality and health?
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31418.
    >> Share

  906. TAYLOR AL, Habibi R, Burci GL, Dagron S, et al
    Solidarity in the wake of COVID-19: reimagining the International Health Regulations.
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31417.
    >> Share

  907. RAVI K
    Ethnic disparities in COVID-19 mortality: are comorbidities to blame?
    Lancet. 2020 Jun 19. pii: S0140-6736(20)31423.
    >> Share

  908. GABSTER BP, van Daalen K, Dhatt R, Barry M, et al
    Challenges for the female academic during the COVID-19 pandemic.
    Lancet. 2020 Jun 18. pii: S0140-6736(20)31412.
    >> Share

  909. SIPIDO KR, Antonanzas F, Celis J, Degos L, et al
    Overcoming fragmentation of health research in Europe: lessons from COVID-19.
    Lancet. 2020 Jun 16. pii: S0140-6736(20)31411.
    >> Share

  910. USHER AD
    COVID-19 vaccines for all?
    Lancet. 2020;395:1822-1823.
    >> Share

  911. HORTON R
    Offline: COVID-19-what we can expect to come.
    Lancet. 2020;395:1821.
    >> Share

  912. NAY O, Kieny MP, Marmora L, Kazatchkine M, et al
    The WHO we want.
    Lancet. 2020;395:1818-1820.
    >> Share

  913. BURZYNSKA K, Contreras G
    Gendered effects of school closures during the COVID-19 pandemic.
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31377.
    >> Share

  914. TREWEEK S, Forouhi NG, Narayan KMV, Khunti K, et al
    COVID-19 and ethnicity: who will research results apply to?
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31380.
    >> Share

  915. MULLER JE, Nathan DG
    COVID-19, nuclear war, and global warming: lessons for our vulnerable world.
    Lancet. 2020 Jun 12. pii: S0140-6736(20)31379.
    >> Share

  916. OKELL LC, Verity R, Watson OJ, Mishra S, et al
    Have deaths from COVID-19 in Europe plateaued due to herd immunity?
    Lancet. 2020 Jun 11. pii: S0140-6736(20)31357.
    >> Share

  917. STRINGHINI S, Wisniak A, Piumatti G, Azman AS, et al
    Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study.
    Lancet. 2020 Jun 11. pii: S0140-6736(20)31304.
    >> Share

  918. LI X, Krumholz HM, Yip W, Cheng KK, et al
    Quality of primary health care in China: challenges and recommendations.
    Lancet. 2020;395:1802-1812.
    >> Share

  919. CURTICE K, Choo E
    Indigenous populations: left behind in the COVID-19 response.
    Lancet. 2020;395:1753.
    >> Share

  920. MULLARD A
    COVID-19 vaccine development pipeline gears up.
    Lancet. 2020;395:1751-1752.
    >> Share

  921. HORTON R
    Offline: COVID-19 and the ethics of memory.
    Lancet. 2020;395:1750.
    >> Share

  922. THE LANCET
    Salient lessons from Russia's COVID-19 outbreak.
    Lancet. 2020;395:1739.
    >> Share

  923. MEHRA MR, Ruschitzka F, Patel AN
    Retraction-Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
    Lancet. 2020 Jun 5. pii: S0140-6736(20)31324.
    >> Share

  924. VON WEYHERN CH, Kaufmann I, Neff F, Kremer M, et al
    Early evidence of pronounced brain involvement in fatal COVID-19 outcomes.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31282.
    >> Share

  925. MENNI C, Sudre CH, Steves CJ, Ourselin S, et al
    Quantifying additional COVID-19 symptoms will save lives.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31281.
    >> Share

  926. LI Z, Chen Q, Feng L, Rodewald L, et al
    Active case finding with case management: the key to tackling the COVID-19 pandemic.
    Lancet. 2020 Jun 4. pii: S0140-6736(20)31278.
    >> Share

  927. THE LANCET EDITORS
    Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
    Lancet. 2020 Jun 3. pii: S0140-6736(20)31290.
    >> Share

  928. MACINTYRE CR, Wang Q
    Physical distancing, face masks, and eye protection for prevention of COVID-19.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31183.
    >> Share

  929. CHU DK, Akl EA, Duda S, Solo K, et al
    Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31142.
    >> Share

  930. CHAN EYY, Gobat N, Kim JH, Newnham EA, et al
    Informal home care providers: the forgotten health-care workers during the COVID-19 pandemic.
    Lancet. 2020 Jun 1. pii: S0140-6736(20)31254.
    >> Share

    May 2020
  931. FRASER B
    COVID-19 strains remote regions of Peru.
    Lancet. 2020;395:1684.
    >> Share

  932. DEVI S
    Fears of "highly catastrophic" COVID-19 spread in Yemen.
    Lancet. 2020;395:1683.
    >> Share

  933. HORTON R
    Offline: After COVID-19-is an "alternate society" possible?
    Lancet. 2020;395:1682.
    >> Share

  934. THE LANCET
    COVID-19 in Africa: no room for complacency.
    Lancet. 2020;395:1669.
    >> Share

  935. MARSTON C, Renedo A, Miles S
    Community participation is crucial in a pandemic.
    Lancet. 2020;395:1676-1678.
    >> Share

  936. CASH R, Patel V
    Has COVID-19 subverted global health?
    Lancet. 2020;395:1687-1688.
    >> Share

  937. GIESECKE J
    The invisible pandemic.
    Lancet. 2020;395:e98.
    >> Share


  938. Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.
    Lancet. 2020 May 29. pii: S0140-6736(20)31182.
    >> Share

  939. PURAS D, de Mesquita JB, Cabal L, Maleche A, et al
    The right to health must guide responses to COVID-19.
    Lancet. 2020 May 29. pii: S0140-6736(20)31255.
    >> Share

  940. POORTMANS PM, Guarneri V, Cardoso MJ
    Cancer and COVID-19: what do we really know?
    Lancet. 2020 May 29. pii: S0140-6736(20)31240.
    >> Share

  941. MYLES PS, Maswime S
    Mitigating the risks of surgery during the COVID-19 pandemic.
    Lancet. 2020 May 29. pii: S0140-6736(20)31256.
    >> Share

  942. LEE LYW, Cazier JB, Starkey T, Turnbull CD, et al
    COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study.
    Lancet. 2020 May 28. pii: S0140-6736(20)31173.
    >> Share

  943. KUDERER NM, Choueiri TK, Shah DP, Shyr Y, et al
    Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
    Lancet. 2020 May 28. pii: S0140-6736(20)31187.
    >> Share

  944. LEE N, McGeer A
    The starting line for COVID-19 vaccine development.
    Lancet. 2020 May 28. pii: S0140-6736(20)31239.
    >> Share

  945. BANATVALA J
    COVID-19 testing delays and pathology services in the UK.
    Lancet. 2020 May 27. pii: S0140-6736(20)31037.
    >> Share

  946. KRIEGER N, Chen JT, Waterman PD
    Excess mortality in men and women in Massachusetts during the COVID-19 pandemic.
    Lancet. 2020 May 27. pii: S0140-6736(20)31234.
    >> Share

  947. ALLEN M, Braithwaite I, Collinson S, Oskrochi Y, et al
    A view from UK public health registrars on the challenges of COVID-19.
    Lancet. 2020 May 27. pii: S0140-6736(20)31058.
    >> Share

  948. STRUWE W, Emmott E, Bailey M, Sharon M, et al
    The COVID-19 MS Coalition-accelerating diagnostics, prognostics, and treatment.
    Lancet. 2020 May 27. pii: S0140-6736(20)31211.
    >> Share

  949. TANG C, Wang Y, Lv H, Guan Z, et al
    Caution against corticosteroid-based COVID-19 treatment.
    Lancet. 2020 May 25. pii: S0140-6736(20)30749.
    >> Share


  950. Assistance Publique-Hopitaux de Paris' response to the COVID-19 pandemic.
    Lancet. 2020 May 25. pii: S0140-6736(20)31210.
    >> Share

  951. MAIER CL, Truong AD, Auld SC, Polly DM, et al
    COVID-19-associated hyperviscosity: a link between inflammation and thrombophilia?
    Lancet. 2020 May 25. pii: S0140-6736(20)31209.
    >> Share

  952. HORTON R
    Offline: Health in the unhappy time of COVID-19.
    Lancet. 2020;395:1600.
    >> Share

  953. THE LANCET
    The plight of essential workers during the COVID-19 pandemic.
    Lancet. 2020;395:1587.
    >> Share

  954. SAINI A
    Stereotype threat.
    Lancet. 2020;395:1604-1605.
    >> Share

  955. LANE R
    Helena Legido-Quigley: proponent of health systems strengthening.
    Lancet. 2020;395:1603.
    >> Share

  956. BURKI T
    England and Wales see 20 000 excess deaths in care homes.
    Lancet. 2020;395:1602.
    >> Share

  957. AGREN D
    Mexican President Lopez Obrador draws doctors' ire.
    Lancet. 2020;395:1601.
    >> Share

  958. FUNCK-BRENTANO C, Salem JE
    Chloroquine or hydroxychloroquine for COVID-19: why might they be hazardous?
    Lancet. 2020 May 22. pii: S0140-6736(20)31174.
    >> Share

  959. GALEA S
    Compassion in a time of COVID-19.
    Lancet. 2020 May 22. pii: S0140-6736(20)31202.
    >> Share

  960. MEHRA MR, Desai SS, Ruschitzka F, Patel AN, et al
    Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.
    Lancet. 2020 May 22. pii: S0140-6736(20)31180.
    >> Share

  961. ZHU FC, Li YH, Guan XH, Hou LH, et al
    Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial.
    Lancet. 2020 May 22. pii: S0140-6736(20)31208.
    >> Share

  962. GROSS R, Conzelmann C, Muller JA, Stenger S, et al
    Detection of SARS-CoV-2 in human breastmilk.
    Lancet. 2020 May 21. pii: S0140-6736(20)31181.
    >> Share

  963. MCKAY D, Heisler M, Mishori R, Catton H, et al
    Attacks against health-care personnel must stop, especially as the world fights COVID-19.
    Lancet. 2020 May 20. pii: S0140-6736(20)31191.
    >> Share

  964. GRASSELLI G, Zanella A
    Critically ill patients with COVID-19 in New York City.
    Lancet. 2020 May 19. pii: S0140-6736(20)31190.
    >> Share

  965. GOLDSMITH CS, Miller SE, Martines RB, Bullock HA, et al
    Electron microscopy of SARS-CoV-2: a challenging task.
    Lancet. 2020 May 19. pii: S0140-6736(20)31188.
    >> Share

  966. CUMMINGS MJ, Baldwin MR, Abrams D, Jacobson SD, et al
    Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.
    Lancet. 2020 May 19. pii: S0140-6736(20)31189.
    >> Share

  967. VARGA Z, Flammer AJ, Steiger P, Haberecker M, et al
    Electron microscopy of SARS-CoV-2: a challenging task - Authors' reply.
    Lancet. 2020 May 19. pii: S0140-6736(20)31185.
    >> Share

  968. GROSS O, Moerer O, Weber M, Huber TB, et al
    COVID-19-associated nephritis: early warning for disease severity and complications?
    Lancet. 2020;395:e87-e88.
    >> Share

  969. CUADRADO-PAYAN E, Montagud-Marrahi E, Torres-Elorza M, Bodro M, et al
    SARS-CoV-2 and influenza virus co-infection.
    Lancet. 2020;395:e84.
    >> Share

  970. LEVERENZ DL, Tarrant TK
    Is the HScore useful in COVID-19?
    Lancet. 2020;395:e83.
    >> Share

  971. WANG Y, Zhang D, Du G, Du R, et al
    Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
    Lancet. 2020;395:1569-1578.
    >> Share

  972. PERINI P, Nabulsi B, Massoni CB, Azzarone M, et al
    Acute limb ischaemia in two young, non-atherosclerotic patients with COVID-19.
    Lancet. 2020;395:1546.
    >> Share

  973. OKANO JT, Blower S
    Preventing major outbreaks of COVID-19 in jails.
    Lancet. 2020;395:1542-1543.
    >> Share

  974. DICKENS BL, Koo JR, Wilder-Smith A, Cook AR, et al
    Institutional, not home-based, isolation could contain the COVID-19 outbreak.
    Lancet. 2020;395:1541-1542.
    >> Share

  975. NORRIE JD
    Remdesivir for COVID-19: challenges of underpowered studies.
    Lancet. 2020;395:1525-1527.
    >> Share

  976. HORTON R
    Offline: Don't let COVID-19 divert us completely.
    Lancet. 2020;395:1534.
    >> Share

  977. AMUASI JH, Walzer C, Heymann D, Carabin H, et al
    Calling for a COVID-19 One Health Research Coalition.
    Lancet. 2020;395:1543-1544.
    >> Share

  978. THORNTON J
    In the aftermath: the legacy of measles in Samoa.
    Lancet. 2020;395:1535-1536.
    >> Share

  979. THE LANCET
    Reviving the US CDC.
    Lancet. 2020;395:1521.
    >> Share

  980. BREWSTER CT, Choong J, Thomas C, Wilson D, et al
    Steam inhalation and paediatric burns during the COVID-19 pandemic.
    Lancet. 2020 May 15. pii: S0140-6736(20)31144.
    >> Share

  981. KAPLAN HS, Trumble BC, Stieglitz J, Mamany RM, et al
    Voluntary collective isolation as a best response to COVID-19 for indigenous populations? A case study and protocol from the Bolivian Amazon.
    Lancet. 2020 May 15. pii: S0140-6736(20)31104.
    >> Share

  982. YANG Y
    Use of herbal drugs to treat COVID-19 should be with caution.
    Lancet. 2020 May 15. pii: S0140-6736(20)31143.
    >> Share

  983. PLATT L, Elmes J, Stevenson L, Holt V, et al
    Sex workers must not be forgotten in the COVID-19 response.
    Lancet. 2020 May 15. pii: S0140-6736(20)31033.
    >> Share

  984. CHIRIBOGA D, Garay J, Buss P, Madrigal RS, et al
    Health inequity during the COVID-19 pandemic: a cry for ethical global leadership.
    Lancet. 2020 May 15. pii: S0140-6736(20)31145.
    >> Share

  985. LEE K, Worsnop CZ, Grepin KA, Kamradt-Scott A, et al
    Global coordination on cross-border travel and trade measures crucial to COVID-19 response.
    Lancet. 2020 May 14. pii: S0140-6736(20)31032.